dia-elearning-storage1000true25001 Participant Newsletters/2025-02-07T01:28:10.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARD25001 Participant Newsletters/25001-February-Newsletter.mp42025-02-07T01:28:44.000Z"dc1246df1c872fc790833f96acc2d7cc-2"CRC64NVMEFULL_OBJECT24386285STANDARDArchive/2021-06-14T15:24:49.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18002/2021-07-08T21:09:08.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18002/18002_Day2_Keynote_Eichler.mp42021-07-08T21:12:41.000Z"8885d61d15bfe837965dee7613791af1-56"959638034STANDARDArchive/18002/18002_Day2_MiddayKeynote1_Kim.mp42021-07-08T21:12:41.000Z"84007172eab0a5e1db9d2b6c2128352b-9"141593959STANDARDArchive/18002/18002_Day2_MidddayKeynote1.2_Khozin.mp42021-07-08T21:12:41.000Z"b6d78e186f3d2758a63ead227c0a0e20-18"299017902STANDARDArchive/18002/18002_Day3_Keynote_Perakslis.mp42021-07-08T21:12:41.000Z"6e99cf70a7725f7cbf197915e2fa4b53-30"514821705STANDARDArchive/18002/18002_Opening_Keynote_McSherry.mp42021-07-08T21:12:41.000Z"1c7eaa9ad7ab2a878733c4375c8f82d3-34"568255628STANDARDArchive/18002/18002_session1.1_Dal Pan.mp42021-07-08T21:23:48.000Z"9fae4c2398f85a8453d9936731ddb46b-20"329356885STANDARDArchive/18002/18002_session1.2_Anderson.mp42021-07-08T21:23:48.000Z"e9d217371078cc4b86b8cd207fb27dd7-19"325259069STANDARDArchive/18002/18002_session1.3_Peters_Chazin.mp42021-07-08T21:23:48.000Z"209f5bc8aa3e3153310518cfbbee7092-26"438204027STANDARDArchive/18002/18002_session10.1_Uzu.mp42021-07-08T21:23:48.000Z"ee070ffa3bd7f9928e9bbf8585aa6766-23"379392079STANDARDArchive/18002/18002_session10.2_Hunt.mp42021-07-08T21:23:48.000Z"6649befd9e4045a0f11cd6dfff312404-19"323107537STANDARDArchive/18002/18002_session10.3_Prokhorova.mp42021-07-08T21:23:48.000Z"77bbb4d31ade3658f8f1b60564a82539-43"727305685STANDARDArchive/18002/18002_session10.4_Johns.mp42021-07-08T21:23:48.000Z"e7237e02f7856a26fa344194a4aa505f-19"312974136STANDARDArchive/18002/18002_session11.1_Coyle.mp42021-07-08T21:23:49.000Z"e1c5199c67f29e126a17a796e775c1b0-13"221518045STANDARDArchive/18002/18002_session11.2_Perrott.mp42021-07-08T21:23:48.000Z"8324cec03cdc6c1337357205529243ea-14"239839851STANDARDArchive/18002/18002_session11.3_Jokinen_Verdru.mp42021-07-08T21:23:48.000Z"d580a4ee05cf78ceb56caf684c0a95b4-24"402948414STANDARDArchive/18002/18002_session11.4_Edwards.mp42021-07-08T21:23:48.000Z"304741aebd17dedd9727ef852c3383f9-14"234449832STANDARDArchive/18002/18002_session2.1_Unger.mp42021-07-08T21:23:49.000Z"f3845f785a51d7b6993fba25b8e0ccf8-16"261293673STANDARDArchive/18002/18002_session2.2_Roache.mp42021-07-08T21:23:49.000Z"d41355caaf21a3e557f5fe79a6dc7254-22"367499115STANDARDArchive/18002/18002_session3_Panel_Presentations.mp42021-07-08T21:23:50.000Z"dda4b7a4dfd8e5abf4c63a2da77a8c63-51"864738436STANDARDArchive/18002/18002_session4.1_Burns.mp42021-07-08T21:23:50.000Z"b5829a6d623c0c83b70e138257019688-17"282789959STANDARDArchive/18002/18002_session4.2_De.mp42021-07-08T21:23:48.000Z"ada6d97d303e266e8363399658b2d5ff-8"136934050STANDARDArchive/18002/18002_session4.3_Bano.mp42021-07-08T22:04:05.000Z"d424184aadc6643409ab4b9997ade16f-16"260565798STANDARDArchive/18002/18002_session5.1_Foy.mp42021-07-08T22:04:05.000Z"4b1c0302da034ca3ae1dccebf6f30b9a-28"471426414STANDARDArchive/18002/18002_session5.2_Edwards.mp42021-07-08T22:04:05.000Z"82b25ba2d44e720ee7d33c721339c735-28"465826343STANDARDArchive/18002/18002_session5.3_Simmons.mp42021-07-08T22:04:05.000Z"e978233b2bb788d66de056fb881f3951-26"432821535STANDARDArchive/18002/18002_session6.1_Mitchell.mp42021-07-08T21:23:49.000Z"ba6e3664b5782ea880c434b978abc328-32"538529433STANDARDArchive/18002/18002_session6.2_Mian_Baker.mp42021-07-08T21:23:49.000Z"4354591f3191c78f6a74557718fc68b7-30"498234232STANDARDArchive/18002/18002_session6.3_Bulliard.mp42021-07-08T21:23:48.000Z"99c2d1d4931d0057cbc4c103c2e4f0fc-19"324054863STANDARDArchive/18002/18002_session7.1_Chonzi.mp42021-07-08T22:04:05.000Z"aeaf4fb92e74b2f234fa45cf9f59f7da-22"377250509STANDARDArchive/18002/18002_session7.2_Tremblay.mp42021-07-08T22:04:05.000Z"4ccca17b53f5489ebd857a3acb28e7a0-21"358979555STANDARDArchive/18002/18002_session7.3_Anderson.mp42021-07-08T21:23:48.000Z"71d9f2725d4186f338a4352502832606-42"713325230STANDARDArchive/18002/18002_session8.1_Dana.mp42021-07-08T22:04:05.000Z"e336f92184c9a513391241fa28c2b476-19"325589672STANDARDArchive/18002/18002_session8.2_Ahluwalia.mp42021-07-08T21:23:48.000Z"991daf4e1cebec2acba24ccaf362325d-17"280986018STANDARDArchive/18002/18002_session8.3_Richardson.mp42021-07-08T22:04:05.000Z"49f5f38fa5e8ed6ad8db851d6e22f68f-15"254821357STANDARDArchive/18002/18002_session8_welcome_Morollo.mp42021-07-08T21:23:48.000Z"eae3d53cb054258cbf9f52a5eb60e72d-8"133070871STANDARDArchive/18002/18002_session9.1_Zammit.mp42021-07-08T22:04:05.000Z"f7bcc59a7e575874b8e3362d493307ea-24"399796430STANDARDArchive/18002/18002_session9.2_Loud.mp42021-07-08T22:04:05.000Z"17d75b8a56969eee578cfe4d0039be2c-14"232491033STANDARDArchive/18006/2021-06-14T15:26:27.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18007/2021-06-14T15:26:27.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18008/2021-06-14T15:26:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18010/2021-06-14T15:26:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18014/2021-06-14T15:26:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18018/2021-06-14T15:26:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18019/2021-06-14T15:26:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18021/2021-06-14T15:26:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18027-need handbrake/2021-06-14T15:26:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18027-need handbrake/18027_10012018_SC_Session1.mp42021-06-14T15:26:24.000Z"b87ed86b4f1b7ced1c5486f1ff26abff-109"1818094595STANDARDArchive/18027-need handbrake/18027_10012018_Sc_Session2-1.mp42021-06-14T15:26:24.000Z"25c619441cdff1bc2412383e49f61df2-4"62443998STANDARDArchive/18027-need handbrake/18027_10012018_Sc_Session3-2.mp42021-06-14T15:26:25.000Z"1a8eb34f8b85f2906458441f37967f5b-10"153101488STANDARDArchive/18027-need handbrake/18027_10012018_Sc_Session4-3.mp42021-06-14T15:26:24.000Z"0f4d19ccbc6fb718e6ccef1384951184-9"136584510STANDARDArchive/18027-need handbrake/18027_10012018_Session02-4.mp42021-06-14T15:26:25.000Z"fb1b20f823e4532be7c3803e54a39626-4"62443998STANDARDArchive/18027-need handbrake/18027_10012018_Session03-5.mp42021-06-14T15:26:24.000Z"cf7b5c0d1e542afbeab85754b520a7c9-10"153101488STANDARDArchive/18027-need handbrake/18027_10022018_Session01-6.mp42021-06-14T15:26:24.000Z"0032528df57d933ccf84efcf8f21fa62-8"122835934STANDARDArchive/18027-need handbrake/18027_10022018_Session04-7.mp42021-06-14T15:26:24.000Z"49a401ecbdea399b9ee34efa3236f8d4-9"147866915STANDARDArchive/18027-need handbrake/18027_10022018_Session05-8.mp42021-06-14T15:26:24.000Z"56b4c9626c678b6a7761893a7f8d3735-11"182438106STANDARDArchive/18027-need handbrake/18027_10032018_Session07-9.mp42021-06-14T15:26:24.000Z"3b5b320804c87e1872d3ab49503bd442-8"128516030STANDARDArchive/18027-need handbrake/18027_10032018_Session08-10.mp42021-06-14T15:26:24.000Z"7547450fba5437b616a11c99726777c0-9"149562746STANDARDArchive/18027-need handbrake/18027_10032018_Session09 Community Update-11.mp42021-06-14T15:26:24.000Z"4201f6e861053126aec064c32f1a26cd-13"214296241STANDARDArchive/18035/2021-06-14T15:26:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18036/2021-06-14T15:26:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18037/2021-06-14T15:26:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18101/2021-06-14T15:26:23.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18303/2021-06-14T15:26:23.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/18975/2021-06-17T13:25:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/2021-06-17T13:24:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/19001_105_42325.mp42021-06-17T13:24:58.000Z"b227c99aef3c52163995dfece46d9d33-40"659089751STANDARDArchive/19001/19001_106_42336.mp42021-06-17T13:24:58.000Z"71efd6051786e0e01f487e7438f686cf-42"693363890STANDARDArchive/19001/19001_107_42462.mp42021-06-17T13:24:58.000Z"498efe63505e07825455fd30da088a51-32"533525987STANDARDArchive/19001/19001_108_42475.mp42021-06-17T13:24:58.000Z"ac8dc5328d714b9ca093c845caf61613-29"481156985STANDARDArchive/19001/19001_109_42480.mp42021-06-17T13:24:58.000Z"39920650660b6a62797392686c8b3197-39"649686104STANDARDArchive/19001/19001_110_42350.mp42021-06-17T13:24:58.000Z"57fcd0e529e4c3c648858bff7b8ea07e-44"727701614STANDARDArchive/19001/19001_111_42356.mp42021-06-17T13:24:58.000Z"6ee8423f89220f607a4b29169e6ec66c-36"600646078STANDARDArchive/19001/19001_112_42366.mp42021-06-17T13:24:58.000Z"b415b2690584f27c881524c99484746d-45"754451413STANDARDArchive/19001/19001_113_42379.mp42021-06-17T13:24:58.000Z"75d58b93a6b53d1b4d9efac7f5f31293-30"492297242STANDARDArchive/19001/19001_114_42395.mp42021-06-17T13:24:58.000Z"ddc2e828df09c56b7d0f85038ad14b64-30"496421500STANDARDArchive/19001/19001_115_42408.mp42021-06-17T13:24:58.000Z"565d3684d69ff84e35ba8904a67772d7-52"859916782STANDARDArchive/19001/19001_116_42417.mp42021-06-17T13:24:58.000Z"199c4e106c73436d0ed8bf4bb6e1a750-31"516544527STANDARDArchive/19001/19001_117_42518.mp42021-06-17T13:24:58.000Z"5288d62247f0485983b591531dea9100-31"519441614STANDARDArchive/19001/19001_118_42450.mp42021-06-17T13:24:58.000Z"3219b68cb1d653ebda147544297b4add-48"791918615STANDARDArchive/19001/19001_119_42452.mp42021-06-17T13:24:58.000Z"d9bf1d33f42b251f960c5bee7cda3ea8-33"542252679STANDARDArchive/19001/19001_120_42458.mp42021-06-17T13:24:58.000Z"37061ecc4f3b71e9c75511a254125fc8-41"686220732STANDARDArchive/19001/19001_121_42498.mp42021-06-17T13:24:58.000Z"83cbec40662ab324bc3c1a17f558f427-30"496162129STANDARDArchive/19001/19001_131_Sb_42563.mp42021-06-17T13:24:58.000Z"f36e1d4151339c8860870b288f2b0fb4-11"174509618STANDARDArchive/19001/19001_135_42337.mp42021-06-17T13:24:58.000Z"d2246e9137202a768ecc7cbce16d2be1-43"710806143STANDARDArchive/19001/19001_136_42341.mp42021-06-17T13:24:58.000Z"c1bc9ff1fff7b85afea78f3539ccb435-42"694826231STANDARDArchive/19001/19001_137_42468.mp42021-06-17T13:24:59.000Z"b51bff0d03ac286922cb381e0b11a776-29"483694607STANDARDArchive/19001/19001_138_42477.mp42021-06-17T13:24:59.000Z"5cace246c6de04c3e6003b516072bea4-24"392968993STANDARDArchive/19001/19001_139_42481.mp42021-06-17T13:24:59.000Z"6a1a53f2cdbeddf76a908069bc5533bd-39"637569987STANDARDArchive/19001/19001_140_42348.mp42021-06-17T13:24:59.000Z"9c776ea0170dc76739b5255ff9c9589d-27"448572759STANDARDArchive/19001/19001_141_42360.mp42021-06-17T13:24:59.000Z"c8b6ea0e79578a1cf493fef0bf5e620f-43"714187127STANDARDArchive/19001/19001_142_42367.mp42021-06-17T13:25:00.000Z"adca9c0d3be643a0fc54e221726a5b81-46"769360081STANDARDArchive/19001/19001_143_42389.mp42021-06-17T13:24:59.000Z"b7744ca0adc2b877e9325a55398928df-43"711676481STANDARDArchive/19001/19001_144_42399.mp42021-06-17T13:24:59.000Z"30462a714ed389a371952a27b7a90a70-53"885724484STANDARDArchive/19001/19001_145_42404.mp42021-06-17T13:24:59.000Z"614eb2a22f70a8d0ad161778fd5b2647-39"647487299STANDARDArchive/19001/19001_146_42418.mp42021-06-17T13:24:59.000Z"4cb85616adffd5ef93489a7d5b23314c-24"386081984STANDARDArchive/19001/19001_147_42519.mp42021-06-17T13:24:59.000Z"fde2d553073ef6942795fb11f9cdae17-45"739981264STANDARDArchive/19001/19001_148_42551.mp42021-06-17T13:24:59.000Z"ecd1deec95dffd31f474efd7d08a382a-33"547485151STANDARDArchive/19001/19001_149_42555.mp42021-06-17T13:24:59.000Z"3eb2f30de3f5d561eef2da4354426713-35"579171094STANDARDArchive/19001/19001_150_42564.mp42021-06-17T13:24:59.000Z"a80245a076a40be26a96270c43390064-36"597295965STANDARDArchive/19001/19001_151_42507.mp42021-06-17T13:24:59.000Z"bca53d4111478735e7bdc99b6b429f8f-45"749493243STANDARDArchive/19001/19001_152_42495.mp42021-06-17T13:24:59.000Z"522cad36d1b373dc176eba84aac459dd-34"570240331STANDARDArchive/19001/19001_153_42538.mp42021-06-17T13:24:59.000Z"a3a04db445eb935240d4e5d4aed7cd6d-27"452622090STANDARDArchive/19001/19001_154_42326.mp42021-06-17T13:24:59.000Z"c4343af4015c0290c128c1ba7dde1b7d-47"781870357STANDARDArchive/19001/19001_155_42544.mp42021-06-17T13:24:59.000Z"d63e15e27b6c28afdef6ef29433430e8-40"655847181STANDARDArchive/19001/19001_156_42472.mp42021-06-17T13:24:59.000Z"7e85bda85c83b32c26a85116f197edb9-46"761500113STANDARDArchive/19001/19001_157_42483.mp42021-06-17T13:25:01.000Z"78ee6d8fdb2830470fbf752a269c16bc-38"637113120STANDARDArchive/19001/19001_158_42488.mp42021-06-17T13:25:00.000Z"ddd3f1850dea4a25d5de2ae78c612a3e-47"783631625STANDARDArchive/19001/19001_159_42352.mp42021-06-17T13:25:00.000Z"7f268e72e86291509e734bac9f0ea861-45"747444587STANDARDArchive/19001/19001_160_42355.mp42021-06-17T13:25:00.000Z"a693b9a9ed24164773224733cfb791e0-11"168857047STANDARDArchive/19001/19001_161_42368.mp42021-06-17T13:25:00.000Z"156bf1326ee25266fd11897d70726c8a-47"784952175STANDARDArchive/19001/19001_162_42380.mp42021-06-17T13:25:00.000Z"b286946c0a5de1f317a364d886c3b46d-41"678819069STANDARDArchive/19001/19001_163_42392.mp42021-06-17T13:25:00.000Z"3dc57273e77b0cd8cf7744cac8daede0-39"644865513STANDARDArchive/19001/19001_164_42410.mp42021-06-17T13:25:00.000Z"14443cfb84f983d7929c2b91884de9cd-27"440725184STANDARDArchive/19001/19001_165_42420.mp42021-06-17T13:25:00.000Z"f6aba46402b2e5b580e990d0dd948fb6-43"709790136STANDARDArchive/19001/19001_166_42421.mp42021-06-17T13:25:00.000Z"ff27829c9bdf04364b9e01d499aa8b85-52"863657253STANDARDArchive/19001/19001_167_42549.mp42021-06-17T13:25:00.000Z"c1a69eb6c04274bb7ffd27da46b97e8b-40"657222024STANDARDArchive/19001/19001_168_42508.mp42021-06-17T13:25:00.000Z"c748c593ec746e2a015f452e59121ffc-47"777470068STANDARDArchive/19001/19001_169_42445.mp42021-06-17T13:25:00.000Z"50a294b0bb301197e4076041e9909666-46"756854575STANDARDArchive/19001/19001_170_42454.mp42021-06-17T13:25:00.000Z"30145569d04f898fa6f66a0f815498e8-36"594809384STANDARDArchive/19001/19001_171_42496.mp42021-06-17T13:25:00.000Z"24147430808395d728c318a37c211e28-24"402256436STANDARDArchive/19001/19001_201_42327.mp42021-06-17T13:25:00.000Z"5c1e029bf9bc155c706676521836e5bf-50"822137909STANDARDArchive/19001/19001_202_42338.mp42021-06-17T13:25:00.000Z"f38f8877a3f2748a6beda0449309619d-50"830025792STANDARDArchive/19001/19001_203_42461.mp42021-06-17T13:25:00.000Z"f6e53b2e679338b2ae69691bbe787f53-45"753823480STANDARDArchive/19001/19001_204_42471.mp42021-06-17T13:25:00.000Z"9d467884012670acfc217dcd8f2f3e02-56"929367109STANDARDArchive/19001/19001_205_42489.mp42021-06-17T13:25:00.000Z"99f637f7e4402e204c8a9e32ecb6ad1d-41"685959823STANDARDArchive/19001/19001_206_42351.mp42021-06-17T13:25:02.000Z"747a81c43ce557c5f3a49ddfe2cac12b-32"533559567STANDARDArchive/19001/19001_207_42361.mp42021-06-17T13:25:02.000Z"e6fbae25021f7a90f652db6e5fd97ef4-33"539111749STANDARDArchive/19001/19001_208_42377.mp42021-06-17T13:25:01.000Z"8d0a805df813daa69394953bfb63f05e-57"951707911STANDARDArchive/19001/19001_209_42386.mp42021-06-17T13:25:01.000Z"f7d919434973fb93f0fab8a42aa0a21e-28"466793953STANDARDArchive/19001/19001_210_42393.mp42021-06-17T13:25:02.000Z"b3bf1e253c559389e163edfc1f92bf85-46"758710369STANDARDArchive/19001/19001_211_42412.mp42021-06-17T13:25:01.000Z"dd28611a6a671bb038d342c3c62d329c-56"924559510STANDARDArchive/19001/19001_212_42413.mp42021-06-17T13:25:02.000Z"6d069dcb195c5fd352de6a1884b07da3-43"718321536STANDARDArchive/19001/19001_213_42422.mp42021-06-17T13:25:01.000Z"83150ac07ab18284daa42309a183d7fe-9"144645626STANDARDArchive/19001/19001_214_42435.mp42021-06-17T13:25:01.000Z"5372e880d8fcb781b02ce0620881daaf-55"908677995STANDARDArchive/19001/19001_215_42545.mp42021-06-17T13:25:02.000Z"a066c5dcb447be51416e6e4fe2879ce7-72"1198068991STANDARDArchive/19001/19001_216_42562.mp42021-06-17T13:25:01.000Z"ffe9ea01a135c9cf2f66908a8f984039-36"603013049STANDARDArchive/19001/19001_217_42509.mp42021-06-17T13:25:02.000Z"970d2439b78935de9d41f43aae232f45-47"785253816STANDARDArchive/19001/19001_218_42444.mp42021-06-17T13:25:01.000Z"939110f959ab5ef0631b96f173bf2bba-41"686246067STANDARDArchive/19001/19001_219_42453.mp42021-06-17T13:25:02.000Z"4f6fa0304bc95871cab83c0b94994548-53"887270587STANDARDArchive/19001/19001_220_42500.mp42021-06-17T13:25:02.000Z"e786f78cfd87240a6759515709e17f2e-40"657848809STANDARDArchive/19001/19001_228_42339.mp42021-06-17T13:25:02.000Z"452d6a37eada01dfd8c84ac360e21f2e-127"2117423403STANDARDArchive/19001/19001_229_42342.mp42021-06-17T13:25:02.000Z"a769d59ee73b89a2b793c92d43648fbe-40"665397271STANDARDArchive/19001/19001_230_42467.mp42021-06-17T13:25:01.000Z"26286092f1c368cdeef6a2c3560c297c-37"612486081STANDARDArchive/19001/19001_231_42474.mp42021-06-17T13:25:01.000Z"95aa4562dfbfb995d61b3398b5d779e9-47"776887759STANDARDArchive/19001/19001_232_42479.mp42021-06-17T13:25:01.000Z"1357618c7f846f5fa48d702b413879cf-43"713564156STANDARDArchive/19001/19001_233_42346.mp42021-06-17T13:25:04.000Z"37362958b17895d62480068c8a95fb20-44"734280218STANDARDArchive/19001/19001_234_42357.mp42021-06-17T13:25:04.000Z"4a94895b9389271328d8251d5599b767-33"548529429STANDARDArchive/19001/19001_235_42369.mp42021-06-17T13:25:04.000Z"fcd083d9afa577dd775995d9b1624385-63"1055481692STANDARDArchive/19001/19001_236_42535.mp42021-06-17T13:25:04.000Z"d44e5cf87cdbe9d84b5a2c991794757e-40"665105629STANDARDArchive/19001/19001_237_42385.mp42021-06-17T13:25:04.000Z"f1a054c90385d922111507ac1696e44b-32"529734220STANDARDArchive/19001/19001_238_42398.mp42021-06-17T13:25:04.000Z"d8b15b9b634b11796d63023652838c31-36"593653867STANDARDArchive/19001/19001_239_42406.mp42021-06-17T13:25:04.000Z"2e378c88ce5de3ba9cc1ff5066396251-31"514389119STANDARDArchive/19001/19001_240_42419.mp42021-06-17T13:25:04.000Z"d6c72ccf6964b80f7336a9b3f17750ef-49"811103872STANDARDArchive/19001/19001_241_42423.mp42021-06-17T13:25:04.000Z"5820b7f015d6f61cffa99eb55f09b628-50"827198351STANDARDArchive/19001/19001_242_42430.mp42021-06-17T13:25:04.000Z"1566ede6c0a2cfb1c5b11f4c2b55f6ad-44"731233969STANDARDArchive/19001/19001_243_42561.mp42021-06-17T13:25:04.000Z"1cbef1b8c57b02eb42dfe4eabbb74a7b-38"624484083STANDARDArchive/19001/19001_244_42510.mp42021-06-17T13:25:04.000Z"75ca620d840e8b4483de80dc23f9c7cb-37"616281819STANDARDArchive/19001/19001_245_42446.mp42021-06-17T13:25:04.000Z"dd43addc94fa471ce08769a89d3c6342-33"548668035STANDARDArchive/19001/19001_246_42455.mp42021-06-17T13:25:04.000Z"9df0c5126d2aff7bea741950c7d18643-24"399587998STANDARDArchive/19001/19001_247_42497.mp42021-06-17T13:25:04.000Z"4921833432551e6b8812c3ccd1142615-45"739716682STANDARDArchive/19001/19001_255_42328.mp42021-06-17T13:25:04.000Z"e04e0792d6e14c1f91d70902ba845b58-31"512499042STANDARDArchive/19001/19001_256_42463.mp42021-06-17T13:25:04.000Z"b97c84f8a332b26d61ee96c1136ab22f-50"838017769STANDARDArchive/19001/19001_257_42473.mp42021-06-17T13:25:04.000Z"0168979aed7a874229e1ff0af0b3b2bd-52"862332206STANDARDArchive/19001/19001_258_42476.mp42021-06-17T13:25:04.000Z"6f487190f6f66f16b0803e747204476f-65"1086474374STANDARDArchive/19001/19001_259_42345.mp42021-06-17T13:25:04.000Z"2aa418fbdd3715c8f953c8c3406087a7-56"927350704STANDARDArchive/19001/19001_260_42365.mp42021-06-17T13:25:06.000Z"31b4d84e1d869ec9fad1b6a2d0edfd97-46"761391831STANDARDArchive/19001/19001_261_42370.mp42021-06-17T13:25:06.000Z"65d858a1df3cf6f7f4b9f3df257c6a9a-92"1530710717STANDARDArchive/19001/19001_262_42626.mp42021-06-17T13:25:06.000Z"1ab1330f54908f01ed9c5a1542954b1e-202"3379587841STANDARDArchive/19001/19001_263_42388.mp42021-06-17T13:25:06.000Z"d91ee4f9920eb475c834d0ccb4b8947c-43"704648832STANDARDArchive/19001/19001_264_ 42390.mp42021-06-17T13:25:06.000Z"29e4936332df5240d57b64076b610348-63"1052648626STANDARDArchive/19001/19001_265_42396.mp42021-06-17T13:25:06.000Z"919735d7ed41ad7b31620504264676e5-21"337122281STANDARDArchive/19001/19001_266_42402.mp42021-06-17T13:25:07.000Z"c589b9d2395e57ec11c96a72f460a61c-53"881232365STANDARDArchive/19001/19001_267_42414.mp42021-06-17T13:25:06.000Z"347fe30db3718301ac4e61650d051a32-65"1080812622STANDARDArchive/19001/19001_268_42431.mp42021-06-17T13:25:06.000Z"a032860cfcced99d4bca411790324e24-62"1024710133STANDARDArchive/19001/19001_269_42436.mp42021-06-17T13:25:06.000Z"edc944132275a552f83b7243836fc0d5-54"905282984STANDARDArchive/19001/19001_270_42511.mp42021-06-17T13:25:06.000Z"abeb69d62b2a2b50ea25dcb60720fb6d-46"767481429STANDARDArchive/19001/19001_271_42449.mp42021-06-17T13:25:06.000Z"389857ef486a63daa6b047ef33bef53b-48"799980883STANDARDArchive/19001/19001_272_42460.mp42021-06-17T13:25:07.000Z"a5fd12aa2d4735f6579f5715e4de60f9-49"819660253STANDARDArchive/19001/19001_273_42499.mp42021-06-17T13:25:06.000Z"4aa515b466fe03cd407f5271656312b4-17"271955194STANDARDArchive/19001/19001_281_42329.mp42021-06-17T13:25:06.000Z"1e49d59506c60ee662ef4641dd79b705-61"1018945499STANDARDArchive/19001/19001_282_42330.mp42021-06-17T13:25:06.000Z"dc4605ee295c2ae571b800f4dfa4705f-48"804002322STANDARDArchive/19001/19001_283_42464.mp42021-06-17T13:25:06.000Z"a4bcbadf5434654d73f930fe4de63a8d-56"936799677STANDARDArchive/19001/19001_284_42470.mp42021-06-17T13:25:06.000Z"edc347503c86127d0581feb7c4f1fa90-38"622023349STANDARDArchive/19001/19001_285_42478.mp42021-06-17T13:25:06.000Z"f22ccf12933344e7b2dc5e823d4484be-46"764015645STANDARDArchive/19001/19001_286_42343.mp42021-06-17T13:25:06.000Z"a8e62a5b5e10767fc7c4ed8bab156248-38"626711691STANDARDArchive/19001/19001_287_42359.mp42021-06-17T13:25:08.000Z"03a0d284c9cc4b67cbd20a2a7d45557a-33"540378697STANDARDArchive/19001/19001_288_42548.mp42021-06-17T13:25:08.000Z"94c7a626922b7f1df7fb6141dd9adb77-37"607150465STANDARDArchive/19001/19001_289_42371.mp42021-06-17T13:25:08.000Z"f4ce5660e3bd84c050cd2dc4481169ca-61"1011303514STANDARDArchive/19001/19001_290_42381.mp42021-06-17T13:25:08.000Z"c760f496c65302604f596bdff4356d61-17"273120151STANDARDArchive/19001/19001_292_42401.mp42021-06-17T13:25:08.000Z"36399d71288f78943f15830b4c698922-34"569267792STANDARDArchive/19001/19001_293_42409.mp42021-06-17T13:25:08.000Z"ecee7487d069efd3f232659edfe18471-56"925827779STANDARDArchive/19001/19001_294_42432.mp42021-06-17T13:25:08.000Z"74bae0c6b1935b7497bea02a447cadb2-55"920834583STANDARDArchive/19001/19001_295_42536.mp42021-06-17T13:25:08.000Z"5c4120f44401e25efe0fa5655aa6d915-62"1036158595STANDARDArchive/19001/19001_296_42556.mp42021-06-17T13:25:08.000Z"27dd97682bd91051243283b77d3af25a-56"937782614STANDARDArchive/19001/19001_297_42512.mp42021-06-17T13:25:08.000Z"e3d7c2b76657e976dde86869b7dda039-70"1163581546STANDARDArchive/19001/19001_298_42441.mp42021-06-17T13:25:08.000Z"d8d47246fd1f42c858851277ecb0feb4-48"797816229STANDARDArchive/19001/19001_299_42457.mp42021-06-17T13:25:08.000Z"66ff9d4169abf09580f49932416124f7-27"451409600STANDARDArchive/19001/19001_301_42340.mp42021-06-17T13:25:08.000Z"eb0625c04790edce3008f72972ba4e6b-56"932418569STANDARDArchive/19001/19001_302_42560.mp42021-06-17T13:25:08.000Z"a68476becc46e9cfa628e91a2fe83a74-52"866552857STANDARDArchive/19001/19001_303_42466.mp42021-06-17T13:25:08.000Z"ce8a60c4fbf20ac6a7dcc9d92d3a1da4-42"691170112STANDARDArchive/19001/19001_304_42491.mp42021-06-17T13:25:08.000Z"d0bb2493ed446571f153039853b45068-45"754140763STANDARDArchive/19001/19001_305_42494.mp42021-06-17T13:25:08.000Z"249b6aa0ca4b07210b0f02d02840a248-63"1049509513STANDARDArchive/19001/19001_306_42347.mp42021-06-17T13:25:08.000Z"4d34178de774b40b15f57e1682635eeb-33"548567254STANDARDArchive/19001/19001_307_42358.mp42021-06-17T13:25:08.000Z"67b71798eb1ebba79e219a049b6d3430-53"888474021STANDARDArchive/19001/19001_308_42372.mp42021-06-17T13:25:08.000Z"d2c78b3f0c211a7bc592bf4ce8a1f9f1-55"908464206STANDARDArchive/19001/19001_309_42387.mp42021-06-17T13:25:11.000Z"c679c04182242db98c35dc863f490eca-56"922775282STANDARDArchive/19001/19001_310_42391.mp42021-06-17T13:25:11.000Z"4ea62c5acd90149e1fe612a9c77a9694-33"549012847STANDARDArchive/19001/19001_311_42405.mp42021-06-17T13:25:11.000Z"c14c6e5cf7466189ee2093c1eb3b9e1e-51"848591008STANDARDArchive/19001/19001_312_42415.mp42021-06-17T13:25:11.000Z"730a78c6e9ef1c9190015b804e0614f7-58"968488508STANDARDArchive/19001/19001_313_42426.mp42021-06-17T13:25:11.000Z"97f9dd8b498e7ab972310623a93aac92-71"1183704755STANDARDArchive/19001/19001_314_42439.mp42021-06-17T13:25:11.000Z"f948b2f659ee6c45a92511098ee815fb-52"858735683STANDARDArchive/19001/19001_315_42513.mp42021-06-17T13:25:11.000Z"dd704133993256b11d07b53630c89d20-47"788254944STANDARDArchive/19001/19001_316_42443.mp42021-06-17T13:25:11.000Z"d6b259be337b44e543454e7595305286-48"796597411STANDARDArchive/19001/19001_317_42447.mp42021-06-17T13:25:11.000Z"2d4e1de397b1f3c2b0871fb869bc57ed-52"859602372STANDARDArchive/19001/19001_318_42451.mp42021-06-17T13:25:11.000Z"3756b5f858cb05f55fa027763ef5d2cc-44"733218574STANDARDArchive/19001/19001_319_42540.mp42021-06-17T13:25:11.000Z"d2488ac0170eeb7fb959c9829a961bc2-43"711528160STANDARDArchive/19001/19001_327_42331.mp42021-06-17T13:25:11.000Z"52940a916fbe3798d8a4a32df05355ce-48"796816269STANDARDArchive/19001/19001_328_42465.mp42021-06-17T13:25:11.000Z"9adf114f9c21d7046939a0fbc5768d74-43"720213331STANDARDArchive/19001/19001_329_42485.mp42021-06-17T13:25:11.000Z"3c212da4306200091fc4c1e1e43286e7-19"303155277STANDARDArchive/19001/19001_330_42493.mp42021-06-17T13:25:11.000Z"1d0b1859f669140e57469dd4ed09dd98-40"669835267STANDARDArchive/19001/19001_331_42552.mp42021-06-17T13:25:11.000Z"0da1687942da66612ad19e5c4d88d565-47"785106238STANDARDArchive/19001/19001_332_42353.mp42021-06-17T13:25:11.000Z"e31a284d31c50813171193f3cdf985e2-37"620183844STANDARDArchive/19001/19001_333_42363.mp42021-06-17T13:25:11.000Z"7ee6efb56d0c1f88ddad966e532c13c1-33"547918606STANDARDArchive/19001/19001_334_42373.mp42021-06-17T13:25:11.000Z"bfa0e15de6b16ca5fcf3b492d41e2732-22"368726214STANDARDArchive/19001/19001_335_42627.mp42021-06-17T13:25:11.000Z"267ac52f0d401c429292ef0f4e0d5f9d-37"616015692STANDARDArchive/19001/19001_336_42546.mp42021-06-17T13:25:12.000Z"2b2ac732b51b1d72be7500e6eb02c535-44"735939823STANDARDArchive/19001/19001_338_42403.mp42021-06-17T13:25:12.000Z"51db5ee83c9e9f97b5baca537c6b03e3-38"629921201STANDARDArchive/19001/19001_339_42427.mp42021-06-17T13:25:12.000Z"933c02b083c1be3cddd98c62ce64dd61-41"679247628STANDARDArchive/19001/19001_340_42433.mp42021-06-17T13:25:12.000Z"90045a06f380a66240160c815e8326e7-48"791418418STANDARDArchive/19001/19001_341_42547.mp42021-06-17T13:25:12.000Z"5eebd63c425eceed22a24ffd91510707-22"367125926STANDARDArchive/19001/19001_342_42553.mp42021-06-17T13:25:12.000Z"e9fbda6a8c3134ac2f0ed48271ada40e-50"831934619STANDARDArchive/19001/19001_343_42514.mp42021-06-17T13:25:12.000Z"666e7894e24f950a23f1cd94a02cbfa3-45"747853784STANDARDArchive/19001/19001_344_42448.mp42021-06-17T13:25:12.000Z"5289a5cc50fa6cf2f089f120d7058763-43"710482251STANDARDArchive/19001/19001_345_42502.mp42021-06-17T13:25:12.000Z"0c277d55d0c09d641547d3019be9d357-25"409499798STANDARDArchive/19001/19001_355_42332.mp42021-06-17T13:25:12.000Z"5f00281d85b897d77f7fbeb4a9a6b3f8-42"693221806STANDARDArchive/19001/19001_356_42619.mp42021-06-17T13:25:12.000Z"e86de0b2ba62a0389711ff9ad84ef823-36"596761902STANDARDArchive/19001/19001_357_42482.mp42021-06-17T13:25:12.000Z"f46e39b8e329c7a2914c2960ad44a9cf-63"1043815588STANDARDArchive/19001/19001_358_42484.mp42021-06-17T13:25:12.000Z"8c64a6f26bc28158155221a128db3eb1-48"796799775STANDARDArchive/19001/19001_359_42487.mp42021-06-17T13:25:12.000Z"9eece0f66589fef6f9576d27aa7fc85a-57"956236794STANDARDArchive/19001/19001_360_42344.mp42021-06-17T13:25:12.000Z"6be194276257fa7dd0c568e99dd72434-56"932446495STANDARDArchive/19001/19001_361_42364.mp42021-06-17T13:25:12.000Z"2cb8b498b6d8063428159672a4839ef6-41"678043065STANDARDArchive/19001/19001_362_42374.mp42021-06-17T13:25:12.000Z"c2493de843948acf6e1bb972181098f5-45"745477389STANDARDArchive/19001/19001_363_42384.mp42021-06-17T13:25:12.000Z"655f4d24b44b09668ca0456f5170206d-46"757953850STANDARDArchive/19001/19001_364_42400.mp42021-06-17T13:25:12.000Z"f12135e9f59253a5b019e56e59e404bc-56"925550287STANDARDArchive/19001/19001_365_42407.mp42021-06-17T13:25:12.000Z"748c8a39efd598b52b304bb2d7120342-43"712288152STANDARDArchive/19001/19001_366_42411.mp42021-06-17T13:25:15.000Z"e3f9c190364c6e4c5220862ad338a427-44"733220024STANDARDArchive/19001/19001_367_42428.mp42021-06-17T13:25:15.000Z"863f44ca755487ecd2ee87e76e8bf4f6-58"968522315STANDARDArchive/19001/19001_368_42434.mp42021-06-17T13:25:15.000Z"2190be9ce3dcb0c6266650738e890db4-31"518218458STANDARDArchive/19001/19001_369_42438.mp42021-06-17T13:25:15.000Z"29f10d5291ea116f9d662cc689876a5a-60"1000136785STANDARDArchive/19001/19001_370_42515.mp42021-06-17T13:25:15.000Z"65608eeb673ae1eea28b039c14f3b91e-57"945422916STANDARDArchive/19001/19001_371_42442.mp42021-06-17T13:25:15.000Z"d06b44d787f5bd1b7a5d630198ac13dd-64"1068905752STANDARDArchive/19001/19001_372_42456.mp42021-06-17T13:25:15.000Z"9b06dc1d6da63fd48ce4d02787b63dfd-28"456342124STANDARDArchive/19001/19001_378_SB_42645.mp42021-06-17T13:25:15.000Z"7656e5eca0e13e524661790b518639f5-6"98025955STANDARDArchive/19001/19001_379_42333.mp42021-06-17T13:25:15.000Z"abaedacf8de58b0e2df1cb193eeb7b7d-49"818971636STANDARDArchive/19001/19001_380_42486.mp42021-06-17T13:25:15.000Z"97d88a3d79e5d2c2d05d1195f9ef1602-68"1138337542STANDARDArchive/19001/19001_381_42490.mp42021-06-17T13:25:15.000Z"448657a544c8b90c5c4f780a396b24f0-51"853558876STANDARDArchive/19001/19001_382_42354.mp42021-06-17T13:25:15.000Z"5bd825b46cee85b0f8e4f4587d39063b-49"812178685STANDARDArchive/19001/19001_383_42362.mp42021-06-17T13:25:15.000Z"745382a2d6c1a6185c65d4dbb619d747-26"419542702STANDARDArchive/19001/19001_384_42375.mp42021-06-17T13:25:15.000Z"aed026eb91602b7b9a987d5b398e88c5-36"603531136STANDARDArchive/19001/19001_385_42383.mp42021-06-17T13:25:15.000Z"2c72d973e38a1401b4d20ac5f7c5d253-52"868222096STANDARDArchive/19001/19001_386_42394.mp42021-06-17T13:25:15.000Z"b68ce4dfd19bbae7f8563cfc60d73192-43"708184886STANDARDArchive/19001/19001_387_42539.mp42021-06-17T13:25:15.000Z"9de6ce4837edd2f4778860955d9510ef-51"851341552STANDARDArchive/19001/19001_388_42424.mp42021-06-17T13:25:15.000Z"80a70132387e060c15141614fbf21042-35"584734178STANDARDArchive/19001/19001_389_42425.mp42021-06-17T13:25:15.000Z"1ca3cd97b4d206e6cdac5e05ce226202-26"420709898STANDARDArchive/19001/19001_390_42429.mp42021-06-17T13:25:15.000Z"a57a677609716f54b76baa7aaf9bc01f-55"919261826STANDARDArchive/19001/19001_391_42557.mp42021-06-17T13:25:16.000Z"2bbdd3ed068a09b761e1225563495922-38"621724352STANDARDArchive/19001/19001_392_42644.mp42021-06-17T13:25:16.000Z"aa33f409c9fec201310b374d4b227452-53"884776285STANDARDArchive/19001/19001_393_42516.mp42021-06-17T13:25:16.000Z"629432853140c9e72a485a7a360d5314-52"861580857STANDARDArchive/19001/19001_394_42440.mp42021-06-17T13:25:16.000Z"66161a0ccf221e0fd6ac921ede956b12-52"862281891STANDARDArchive/19001/19001_395_42541.mp42021-06-17T13:25:16.000Z"6ee4cc521a32c4812ca91440cf20fc71-47"783369999STANDARDArchive/19001/19001_396_42459.mp42021-06-17T13:25:16.000Z"ca9c428e1b359893f66386e5e333b4d6-63"1054054312STANDARDArchive/19001/19001_397_42537.mp42021-06-17T13:25:16.000Z"37ca3a183d8a1bc12a6fc09f5e117de7-42"703197166STANDARDArchive/19001/19001_403_42334.mp42021-06-17T13:25:16.000Z"2743fef553a6e040060124781b88154d-65"1090152831STANDARDArchive/19001/19001_404_42469.mp42021-06-17T13:25:16.000Z"56d8442e83fd08320b73b35c2aa08102-56"935366459STANDARDArchive/19001/19001_405_42492.mp42021-06-17T13:25:16.000Z"a5b33942574f78f704368c81f5d2a349-51"840120209STANDARDArchive/19001/19001_406_42349.mp42021-06-17T13:25:17.000Z"86a691908b16afe0130c96ea72c04d20-42"701946627STANDARDArchive/19001/19001_407_42376.mp42021-06-17T13:25:16.000Z"4ff90661104af76bad88ab70638651fd-74"1240556837STANDARDArchive/19001/19001_408_42378.mp42021-06-17T13:25:16.000Z"367a6e728276ff7d6820a39c219c261f-52"859957158STANDARDArchive/19001/19001_409_42416.mp42021-06-17T13:25:16.000Z"64fe8668faa2f0912f821b809987c118-42"696534833STANDARDArchive/19001/19001_410_42437.mp42021-06-17T13:25:16.000Z"701165df29b1a3b08593e00b1da132e7-47"782460775STANDARDArchive/19001/19001_411_42517.mp42021-06-17T13:25:16.000Z"078ef2f07ebf27ab5bd23cbdf441ed67-75"1256101817STANDARDArchive/19001/19001_412_42542.mp42021-06-17T13:25:16.000Z"604f3d1b0d6e58cfd8d35f68e4741445-43"708777062STANDARDArchive/19001/19001_413_42543.mp42021-06-17T13:25:16.000Z"832abd4c42bb1422805f32fcf20af00f-48"802139383STANDARDArchive/19001/19001_Opening_Plenary.mp42021-06-17T13:25:16.000Z"1674d48f7dac745d5daf6130aea7ca69-91"1511882180STANDARDArchive/19001/7472486/2021-06-17T13:24:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/7472486/Artificial-Intelligence-in-Drug-Discovery-and-Development-Emerging-Technologies-and-Applications-captions.vtt2021-06-17T13:24:55.000Z"0180c227ba1304f5797f86b44de33a1b"86649STANDARDArchive/19001/7472486/Artificial-Intelligence-in-Drug-Discovery-and-Development-Emerging-Technologies-and-Applications-poster.jpg2021-06-17T13:24:55.000Z"eb10628abb2fc349e0565884f5abfa39"430207STANDARDArchive/19001/7788227/2021-06-17T13:24:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/7788227/Addressing-Heterogeneity-of-Real-World-Evidence-in-Drug-Safety-Audio.m4a2021-06-17T13:25:17.000Z"8fb96dfc64f5d111272ab94c8ac3c248-6"92961107eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788227/Addressing-Heterogeneity-of-Real-World-Evidence-in-Drug-Safety-Tile.jpg2021-06-17T13:24:55.000Z"458c6c33f9269bc53bfab428fa19df37"81848STANDARDArchive/19001/7788227/Addressing-Heterogeneity-of-Real-World-Evidence-in-Drug-Safety-captions.vtt2021-06-17T13:24:55.000Z"35b8b4efc87e9836b70bbf71de15125a"86281eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788227/Addressing-Heterogeneity-of-Real-World-Evidence-in-Drug-Safety-chapters.vtt2021-06-17T13:24:55.000Z"cad3f451416dbcde16267fae5d60d9ac"42STANDARDArchive/19001/7788227/Addressing-Heterogeneity-of-Real-World-Evidence-in-Drug-Safety.jpg2021-06-17T13:24:55.000Z"f84225770942e2288ea199cfd1bb4355"719020STANDARDArchive/19001/7788227/Adrian_Levy.pdf2021-06-17T13:24:55.000Z"729056becef17fb5da976f313189e6b0"1132435STANDARDArchive/19001/7788227/Alicia_Gilsenan.pdf2021-06-17T13:24:55.000Z"95e63a1d2cf610b0da3fa35bce903e48"1132968STANDARDArchive/19001/7788227/Huei_Ting_Tsai.pdf2021-06-17T13:24:55.000Z"7c42e01d8531211a99c0ffd02102447a"286202STANDARDArchive/19001/7788227/Michael_Blum.pdf2021-06-17T13:24:55.000Z"732914c57d5cbed01844489cace72b43"783577STANDARDArchive/19001/7788380/2021-06-17T13:24:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/7788380/Bruce_Donzanti.pdf2021-06-17T13:24:55.000Z"1cab7631935778761228fee00b7fc8b0"544172STANDARDArchive/19001/7788380/Lisa_George.pdf2021-06-17T13:24:55.000Z"e46ed0a155743991e0f50641d25929fa"747403STANDARDArchive/19001/7788380/Mick_Foy_01_Pharma_and_Regulatoru.pdf2021-06-17T13:24:55.000Z"a0926765e2c1cde98cc14368fbddb81c"725108STANDARDArchive/19001/7788380/Pharma-and-Regulatory-Perspectives-on-Machine-Learning-Applications-in-Pharmacovigilance-Tile.jpg2021-06-17T13:24:55.000Z"4a78ba74bee28df51597e57616c324f1"50185STANDARDArchive/19001/7788380/Pharma-and-Regulatory-Perspectives-on-Machine-Learning-Applications-in-Pharmacovigilance.jpg2021-06-17T13:24:55.000Z"74800a33181411d8b969a817538f3dbe"467935STANDARDArchive/19001/7788380/Pharma-and-Regulatory-Perspectives-on-Machine-Learning-Applications-in-Pharmacovigilance.mp42021-06-17T13:25:19.000Z"e04e0792d6e14c1f91d70902ba845b58-31"512499042STANDARDArchive/19001/7788380/Robert_Ball.pdf2021-06-17T13:24:55.000Z"dbfb6537d34ba31e75536e033046f8ad"905296STANDARDArchive/19001/7788394/2021-06-17T13:24:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/7788394/Carmit_Strauss.pdf2021-06-17T13:24:55.000Z"7530b60046d95c904fbd2b5714dd16f1"570708STANDARDArchive/19001/7788394/Digital-Risk-Minimization-The-Next-Generation-Risk-Management-Tools-Audio.m4a2021-06-17T13:25:19.000Z"0f2d8121bbb9418a0a1e82abb7d9cf17-6"92013959eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788394/Digital-Risk-Minimization-The-Next-Generation-Risk-Management-Tools-Tile.jpg2021-06-17T13:24:55.000Z"263149396cc3cace1457cbd5fc30325d"50554STANDARDArchive/19001/7788394/Digital-Risk-Minimization-The-Next-Generation-Risk-Management-Tools-captions.vtt2021-06-17T13:24:55.000Z"d4a85b1a5149a23c8206f5f40c7d714b"94025eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788394/Digital-Risk-Minimization-The-Next-Generation-Risk-Management-Tools.jpg2021-06-17T13:24:55.000Z"7c63c84cc8dd93dc75e9c72fcf5d1c77"475483STANDARDArchive/19001/7788394/Digital-Risk-Minimization-The-Next-Generation-Risk-Management-Tools.mp42021-06-17T13:25:19.000Z"52940a916fbe3798d8a4a32df05355ce-48"796816269STANDARDArchive/19001/7788394/Sarah_Frise.pdf2021-06-17T13:24:55.000Z"c2349205679461d83b111a16b3b56598"1201056STANDARDArchive/19001/7788394/Simon_Ingate.pdf2021-06-17T13:24:55.000Z"7ca8eaa9a8c2f04c04d5a0a581b59805"1084705STANDARDArchive/19001/7788411/2021-06-17T13:24:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/7788411/Cynthia_LaCivita.pdf2021-06-17T13:24:55.000Z"712e65f1eec945d9dd6a323d836a28b2"1133840STANDARDArchive/19001/7788411/Elaine_Morrato.pdf2021-06-17T13:24:55.000Z"34fb876b3538aaebcdad8adeb8d6f59b"2340078STANDARDArchive/19001/7788411/Gita_Toyserkani.pdf2021-06-17T13:24:55.000Z"84b02bf1dc9b85025ae3f61aedd6ce67"1106715STANDARDArchive/19001/7788411/Hilda_Chan.pdf2021-06-17T13:24:55.000Z"2cb5278e9bf3a229fe43b60e4711bf49"609095STANDARDArchive/19001/7788411/History-of-Risk-Evaluation-and-Mitigation-Strategies-REMS-What-Have-We-Learned-Audio.m4a2021-06-17T13:25:19.000Z"ce0082151c6882c6ba268ae5f62fc8c8-7"116713468eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788411/History-of-Risk-Evaluation-and-Mitigation-Strategies-REMS-What-Have-We-Learned-Tile.jpg2021-06-17T13:24:55.000Z"79424caba5ad877c8b7e6d26475f9d34"75341STANDARDArchive/19001/7788411/History-of-Risk-Evaluation-and-Mitigation-Strategies-REMS-What-Have-We-Learned-captions.vtt2021-06-17T13:24:55.000Z"4e911f319044f4c1f0494f52887be293"116711eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788411/History-of-Risk-Evaluation-and-Mitigation-Strategies-REMS-What-Have-We-Learned.jpg2021-06-17T13:24:55.000Z"91b1dff32f46ecca6831c205aef2183f"681482STANDARDArchive/19001/7788411/History-of-Risk-Evaluation-and-Mitigation-Strategies-REMS-What-Have-We-Learned.mp42021-06-17T13:25:19.000Z"5f00281d85b897d77f7fbeb4a9a6b3f8-42"693221806STANDARDArchive/19001/7788447/2021-06-17T13:24:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/7788447/Brad_Jordan.pdf2021-06-17T13:24:55.000Z"61e68a3b403cfc0f8689e601779f6cab"1001721STANDARDArchive/19001/7788447/Brian_Edwards.pdf2021-06-17T13:24:55.000Z"f72cf6253084b051fd96d8a2f2c661d0"1575461STANDARDArchive/19001/7788447/Kalindi_Hapani.pdf2021-06-17T13:24:55.000Z"f1cabd08f447da3b5c1d5f2bdc2d02a0"643380STANDARDArchive/19001/7788447/Lubna_Merchant.pdf2021-06-17T13:24:55.000Z"24c42ff513f8e0033897fe3b283bdad8"717427STANDARDArchive/19001/7788447/Philip_Schneider.pdf2021-06-17T13:24:56.000Z"53100ad061bd34c86aa4187d51b0b1f4"1528113STANDARDArchive/19001/7788447/Successes-and-Challenges-in-Pharmacovigilance-for-Biologics-and-Biosimilars-Tile.jpg2021-06-17T13:24:56.000Z"296b940c3f304e1eed34609118ea6479"55953STANDARDArchive/19001/7788447/Successes-and-Challenges-in-Pharmacovigilance-for-Biologics-and-Biosimilars.jpg2021-06-17T13:24:56.000Z"a4aef392291e7de50d13e920de01d2dc"509871STANDARDArchive/19001/7788447/Successes-and-Challenges-in-Pharmacovigilance-for-Biologics-and-Biosimilars.mp42021-06-17T13:25:19.000Z"2743fef553a6e040060124781b88154d-65"1090152831STANDARDArchive/19001/7788520/2021-06-17T13:24:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/7788520/Brian_Edwards_01_Moving_forward_in_EU_PV.pdf2021-06-17T13:24:56.000Z"f39826172562e6c52a20e74bd4399ac1"859662STANDARDArchive/19001/7788520/François_Houyez.pdf2021-06-17T13:24:56.000Z"c3c6e162fe0d661642fc4403519e79e6"4067998STANDARDArchive/19001/7788520/Jeremy_Rassen.pdf2021-06-17T13:24:56.000Z"ccb3d5e9710f3973817abcc5b9697d18"1127972STANDARDArchive/19001/7788520/Moving-Forward-in-EU-Pharmacovigilance-Audio.m4a2021-06-17T13:25:19.000Z"490806c6dfd1995ccc56c5241eac853e-6"92962237eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788520/Moving-Forward-in-EU-Pharmacovigilance-Tile.jpg2021-06-17T13:24:56.000Z"23248e0ab52dce424c3558598c59a027"85600STANDARDArchive/19001/7788520/Moving-Forward-in-EU-Pharmacovigilance-captions.vtt2021-06-17T13:24:56.000Z"15d39a34f37772f9e21c15345489d675"88578eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788520/Moving-Forward-in-EU-Pharmacovigilance.jpg2021-06-17T13:24:56.000Z"a0175b193403db64cfd163df7ae50c64"784695eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788568/2021-06-17T13:24:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/7788568/Kimberly_Brodovicz.pdf2021-06-17T13:24:56.000Z"443231ac432d8be1b39113c753bfce63"862624STANDARDArchive/19001/7788568/Noelle_Cocoros.pdf2021-06-17T13:24:56.000Z"b4fdc9a8850c98e4d1654b28eb5d1aee"708911STANDARDArchive/19001/7788568/Robert_Massouh.pdf2021-06-17T13:24:56.000Z"756d3f1945f28c32300c167d313a8971"791174STANDARDArchive/19001/7788568/Using-Real-World-Data-to-Develop-a-Safety-Monitoring-Program-and-Ensure-Pre-and-Post-Market-Continuity-Audio.m4a2021-06-17T13:25:19.000Z"c42e10c7c54dccccd5e08cf5df54dc82-6"88250812eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788568/Using-Real-World-Data-to-Develop-a-Safety-Monitoring-Program-and-Ensure-Pre-and-Post-Market-Continuity-Tile.jpg2021-06-17T13:24:56.000Z"3009cedaa28f88f846976b667b506332"51852STANDARDArchive/19001/7788568/Using-Real-World-Data-to-Develop-a-Safety-Monitoring-Program-and-Ensure-Pre-and-Post-Market-Continuity-captions.vtt2021-06-17T13:24:56.000Z"75e1597ac6d6994a21f0c50327a59bd9"89637eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788568/Using-Real-World-Data-to-Develop-a-Safety-Monitoring-Program-and-Ensure-Pre-and-Post-Market-Continuity.jpg2021-06-17T13:24:56.000Z"73f7278b5f5647969fa98c3ae8a390f3"501828STANDARDArchive/19001/7788657/2021-06-17T13:24:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/7788657/Jose_Vega.pdf2021-06-17T13:24:56.000Z"d38e99208a972640c194fb3a0ef69a92"2068877STANDARDArchive/19001/7788657/Updates-and-Lessons-Learned-from-Novel-Approaches-to-Pharmacovigilance-Collaboration-Audio.m4a2021-06-17T13:25:19.000Z"c20ca34ef7238b33c29e374ea5be6264-6"97249231eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788657/Updates-and-Lessons-Learned-from-Novel-Approaches-to-Pharmacovigilance-Collaboration-Tile.jpg2021-06-17T13:24:56.000Z"d4199205918be6738ba63c3547536fc5"55823STANDARDArchive/19001/7788657/Updates-and-Lessons-Learned-from-Novel-Approaches-to-Pharmacovigilance-Collaboration-captions.vtt2021-06-17T13:24:57.000Z"43b94e28cbac8b601918d602a80fc469"96139eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788657/Updates-and-Lessons-Learned-from-Novel-Approaches-to-Pharmacovigilance-Collaboration.jpg2021-06-17T13:24:57.000Z"49f10185df0a9891046db75edbeac9fe"479366eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/7788657/Updates-and-Lessons-Learned-from-Novel-Approaches-to-Pharmacovigilance-Collaboration.mp42021-06-17T13:25:19.000Z"f38f8877a3f2748a6beda0449309619d-50"830025792STANDARDArchive/19001/7788686/2021-06-17T13:24:57.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/7788686/Ajay_Singh.pdf2021-06-17T13:24:57.000Z"95275b1a9973f2abcc8152581a9085e5"2020509STANDARDArchive/19001/7788686/Interpretation-of-New-Pharmacovigilance-Regulations-Key-Insights-Audio.m4a2021-06-17T13:25:20.000Z"efe6c7a23a1cb3d8875041e6ad89c395-6"92782972STANDARDArchive/19001/7788686/Interpretation-of-New-Pharmacovigilance-Regulations-Key-Insights-Tile.jpg2021-06-17T13:24:57.000Z"372dad0508e2c8a01ba2054547fc6bfa"54498STANDARDArchive/19001/7788686/Interpretation-of-New-Pharmacovigilance-Regulations-Key-Insights-captions.vtt2021-06-17T13:24:57.000Z"1e3d67ab150fadafaacbcc8caca196ae"90305STANDARDArchive/19001/7788686/Interpretation-of-New-Pharmacovigilance-Regulations-Key-Insights-chapters.vtt2021-06-17T13:24:57.000Z"cad3f451416dbcde16267fae5d60d9ac"42STANDARDArchive/19001/7788686/Interpretation-of-New-Pharmacovigilance-Regulations-Key-Insights.jpg2021-06-17T13:24:57.000Z"e654627d738f5ede675281aebdccd64d"501761STANDARDArchive/19001/7788686/Mick_Foy.pdf2021-06-17T13:24:57.000Z"61e3fded86d04b35c2a2962bbb6d8852"534998STANDARDArchive/19001/8015845/2021-06-17T13:25:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/8015845/Andrea_Best.pdf2021-06-17T13:25:24.000Z"e262e329dc47856b8aabd49f9f08375a"1023838STANDARDArchive/19001/8015845/Mick_Foy.pdf2021-06-17T13:25:24.000Z"f3c94dff4e93637ca1d0f8f66ddc9fa3"1376294STANDARDArchive/19001/8015845/Raj_Long.pdf2021-06-17T13:25:24.000Z"d66f17cf29fac1e7ddddc3a9ba751a74"1940116STANDARDArchive/19001/8015845/Triple-s-3S-Smart-Safety-Surveillance-Audio.m4a2021-06-17T13:25:28.000Z"b313cee8410ff002c6ed0adee1f6c61a-7"110108654eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/8015845/Triple-s-3S-Smart-Safety-Surveillance-Tile.jpg2021-06-17T13:25:24.000Z"a4886ff8d858c23404a1ddc6febeb6d3"55994STANDARDArchive/19001/8015845/Triple-s-3S-Smart-Safety-Surveillance-captions.vtt2021-06-17T13:25:24.000Z"362ba853f6eb55cd0cfe5cde3f81b3ac"114388eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19001/8015845/Triple-s-3S-Smart-Safety-Surveillance.jpg2021-06-17T13:25:24.000Z"db9c20c459deb3146b8481bbcad9c691"463076STANDARDArchive/19001/8015845/Triple-s-3S-Smart-Safety-Surveillance.mp42021-06-17T13:25:28.000Z"a68476becc46e9cfa628e91a2fe83a74-52"866552857STANDARDArchive/19001/8069631/2021-06-17T13:25:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/8069631/Involving-Patients-in-Medicinal-Product-Benefit-Risk-Communication-How-re-We-Doing-Tile.jpg2021-06-17T13:25:24.000Z"77ea0657a00ed27590c8657caa1261a3"56940STANDARDArchive/19001/8069631/Involving-Patients-in-Medicinal-Product-Benefit-Risk-Communication-How-re-We-Doing.jpg2021-06-17T13:25:24.000Z"8a2f065becd1f0102d2920173133f94b"550353STANDARDArchive/19001/8069631/Involving-Patients-in-Medicinal-Product-Benefit-Risk-Communication-How-re-We-Doing.mp42021-06-17T13:25:28.000Z"e86de0b2ba62a0389711ff9ad84ef823-36"596761902STANDARDArchive/19001/8069631/Marc_Boutin.pdf2021-06-17T13:25:24.000Z"41be6a0bc2327025a3d1a4910eb11bf8"1271805STANDARDArchive/19001/8069631/Meredith_Smith.pdf2021-06-17T13:25:24.000Z"69b1ca301bb7cb2d9905c2d28505402a"958650STANDARDArchive/19001/8069631/Tânia_Teixeira.pdf2021-06-17T13:25:24.000Z"a151607e98d2c82570d9a456f07794d1"478418STANDARDArchive/19001/8114816/2021-06-17T13:25:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/8114816/Ajay_Singh.pdf2021-06-17T13:25:24.000Z"95275b1a9973f2abcc8152581a9085e5"2020509STANDARDArchive/19001/8114816/Mick_Foy.pdf2021-06-17T13:25:24.000Z"61e3fded86d04b35c2a2962bbb6d8852"534998STANDARDArchive/19001/8114816/Round-Table-Discussion-Interpretation-of-New-Pharmacovigilance-Regulations-Key-Insights-Audio.m4a2021-06-17T13:25:28.000Z"efe6c7a23a1cb3d8875041e6ad89c395-6"92782972STANDARDArchive/19001/8114816/Round-Table-Discussion-Interpretation-of-New-Pharmacovigilance-Regulations-Key-Insights-captions.vtt2021-06-17T13:25:24.000Z"1e3d67ab150fadafaacbcc8caca196ae"90305STANDARDArchive/19001/8114816/Round-Table-Discussion-Interpretation-of-New-Pharmacovigilance-Regulations-Key-Insights-chapters.vtt2021-06-17T13:25:24.000Z"cad3f451416dbcde16267fae5d60d9ac"42STANDARDArchive/19001/DIA 19001 PVS.zip2021-06-17T13:25:28.000Z"795a6ddb64b95e53f990e813a071c4ee-58"960214890STANDARDArchive/19001/Synched_final.mp42021-06-17T13:25:28.000Z"c11e8634f03af3565d3afb2116b42f22-207"3472518156STANDARDArchive/19001/additional video files/2021-06-17T13:25:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19001/additional video files/19001_262_42626.mp42021-06-17T13:25:28.000Z"1ab1330f54908f01ed9c5a1542954b1e-202"3379587841STANDARDArchive/19001/additional video files/DIA_2019_Wide_angle_camera.mp42021-06-17T13:25:28.000Z"518141c15f7227dcc3b35d3748e4da42-347"5819088025STANDARDArchive/19001/additional video files/Regulatory-Town-Hall.mp42021-06-17T13:25:28.000Z"7c320b35d92cb8239423118c67d71a68-44"724645846STANDARDArchive/19002/2021-06-17T13:24:52.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19002/19002_01_190128-1.mp42021-06-17T13:24:54.000Z"1f17f37054f6876c02c012c8a790f9e7-9"140321564STANDARDArchive/19002/19002_02_190128-1.mp42021-06-17T13:24:54.000Z"38014c1616474e88639c47beae8623f5-11"179459677STANDARDArchive/19002/19002_03_190128-1.mp42021-06-17T13:24:54.000Z"3347e2cd324217eacd41ddc510cf9296-5"75880089STANDARDArchive/19002/19002_04_190128-1.mp42021-06-17T13:24:54.000Z"c17594023287ea08b763c1715a6bd939-6"91889051STANDARDArchive/19002/19002_05_190128-1.mp42021-06-17T13:24:54.000Z"ef28a62d911c99615f517c8c5aa4fe53-10"162829828STANDARDArchive/19002/19002_06_190129-1.mp42021-06-17T13:24:54.000Z"e47675ab4f1a495950d651b5b3cbb116-10"156533473STANDARDArchive/19002/19002_07_190129-1.mp42021-06-17T13:24:54.000Z"7134f84c3043094561c09099d59bba86-11"182680865STANDARDArchive/19002/19002_08_190129-1.mp42021-06-17T13:24:54.000Z"5d53d4093b6721b752f6c8aa66ba08e6-12"187744476STANDARDArchive/19002/19002_09_190129-1.mp42021-06-17T13:24:54.000Z"930cc6d8270d8a8dee20647289a135b7-8"122464782STANDARDArchive/19002/19002_10_190130-1.mp42021-06-17T13:24:54.000Z"1f2b301552412fd9b29595d909a7ace5-10"152772789STANDARDArchive/19002/19002_11_190130-1.mp42021-06-17T13:24:54.000Z"382546d25a850eef65bda48af34d22ac-7"113131933STANDARDArchive/19002/19002_12_190130-1.mp42021-06-17T13:24:54.000Z"b5c6396d17b83e6bccd315bef6f1456b-10"156305625STANDARDArchive/19002/19002_13_190130-2.mp42021-06-17T13:24:54.000Z"9e0dc441fd693bba7aa6481010f01d4a-8"123474146STANDARDArchive/19002/19002_14_190130-3.mp42021-06-17T13:24:54.000Z"0d9d2abe60132d6bb801f4b1ac43a643-8"122128227STANDARDArchive/19002/19002_Shortcourse 1-4.mp42021-06-17T13:24:54.000Z"8f999392a351910ec94ce6daf13bbacf-31"504565561STANDARDArchive/19002/7639554/2021-06-17T13:24:52.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19002/7639554/1.0_19002_Dal_Pan.pdf2021-06-17T13:24:52.000Z"96840c6f37dbc6b40c5d1fa0c978243b"1881113STANDARDArchive/19002/7639554/1.2_19002_Feibus.pdf2021-06-17T13:24:52.000Z"c590887ae4d1d8a02b22348f496a5273"612791STANDARDArchive/19002/7639554/Session-1-FDA-Updates-Audio.m4a2021-06-17T13:24:52.000Z"79bd5f405baaf42e595b686ab067a190"10654346eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639554/Session-1-FDA-Updates-Tile.jpg2021-06-17T13:24:52.000Z"f840d791357e7c5e6c40925ec5d5f9c3"134136STANDARDArchive/19002/7639554/Session-1-FDA-Updates-captions.vtt2021-06-17T13:24:52.000Z"a6e90922499b43cd94e3de1b9628b2cc"102440eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639554/Session-1-FDA-Updates.jpg2021-06-17T13:24:52.000Z"fc21b76c4b3b8ae281f1a7489a4fc5ae"655762eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639554/Session-1-FDA-Updates.mp42021-06-17T13:24:54.000Z"1f17f37054f6876c02c012c8a790f9e7-9"140321564STANDARDArchive/19002/7639568/2021-06-17T13:24:52.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19002/7639568/5.1_19002_Mba-Jonas.pdf2021-06-17T13:24:52.000Z"a02183c5ab746da8913a7824e34dd714"928284STANDARDArchive/19002/7639568/5.4_19002_Chonzi.pdf2021-06-17T13:24:52.000Z"b4c8fe84530a5845554b5c709852f0fd"182292STANDARDArchive/19002/7639568/Session-5-Advanced-Therapies-Tile.jpg2021-06-17T13:24:52.000Z"4c3c27eeda3dfd5f3f3e276172b50e0f"133659STANDARDArchive/19002/7639568/Session-5-Advanced-Therapies.jpg2021-06-17T13:24:52.000Z"d73784e59925852cfce14162022b7ff6"643545STANDARDArchive/19002/7639568/Session-5-Advanced-Therapies.mp42021-06-17T13:24:54.000Z"ef28a62d911c99615f517c8c5aa4fe53-10"162829828STANDARDArchive/19002/7639574/2021-06-17T13:24:52.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19002/7639574/6.1_19002_Foy .pdf2021-06-17T13:24:52.000Z"413b9e500ddd55072558dd07b8aa6d37"93319STANDARDArchive/19002/7639574/6.2_19002_Edwards .pdf2021-06-17T13:24:52.000Z"3e7a4ad0846db1a92f33bd637cf281f0"403009STANDARDArchive/19002/7639574/6.3_19002_Simmons .pdf2021-06-17T13:24:52.000Z"cdaeb9abd761c999506244a3a14bfb1b"1700824STANDARDArchive/19002/7639574/Session-6-EU-Updates-Tile.jpg2021-06-17T13:24:52.000Z"efa77f21a6c7a57652e5eaa210c75491"115145STANDARDArchive/19002/7639574/Session-6-EU-Updates.jpg2021-06-17T13:24:52.000Z"64de183e07a43b3daa781818169c6836"646919STANDARDArchive/19002/7639574/Session-6-EU-Updates.mp42021-06-17T13:24:54.000Z"e47675ab4f1a495950d651b5b3cbb116-10"156533473STANDARDArchive/19002/7639584/2021-06-17T13:24:52.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19002/7639584/7.1_19002_Schneeweiss.pdf2021-06-17T13:24:53.000Z"cf13355a7e728ade6d998cc8877dae33"1285018STANDARDArchive/19002/7639584/Session-7-Epidemiology-and-RWE-Audio.m4a2021-06-17T13:24:54.000Z"fd507557bcbab02fbea90d9bd3793483-9"143695372eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639584/Session-7-Epidemiology-and-RWE-Tile.jpg2021-06-17T13:24:53.000Z"e6dc7871d0082f7129d362a238fd753e"44254STANDARDArchive/19002/7639584/Session-7-Epidemiology-and-RWE-captions.vtt2021-06-17T13:24:53.000Z"e594b5454a1fda2d1ed7cb8ce7613178"150077eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639584/Session-7-Epidemiology-and-RWE-chapters.vtt2021-06-17T13:24:53.000Z"cad3f451416dbcde16267fae5d60d9ac"42STANDARDArchive/19002/7639584/Session-7-Epidemiology-and-RWE.jpg2021-06-17T13:24:53.000Z"560a123c168b9d00fef1294e292fd8f2"377587STANDARDArchive/19002/7639584/Session-7-Epidemiology-and-RWE.mp42021-06-17T13:24:54.000Z"7134f84c3043094561c09099d59bba86-11"182680865STANDARDArchive/19002/7639596/2021-06-17T13:24:53.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19002/7639596/13.1_19002_Ashby.pdf2021-06-17T13:24:53.000Z"b78a0ed1715904156937420d9160dfc7"440564STANDARDArchive/19002/7639596/13.2_19002_Piccirillo.pdf2021-06-17T13:24:53.000Z"50d2b3a0d9b73c5b832b9dd940177b9e"223105STANDARDArchive/19002/7639596/Session-13-Benefit-Risk-in-Decision-Making-Audio.m4a2021-06-17T13:24:54.000Z"323c3d07b7b4a2b2a577ecb7028c83f0-6"99112668eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639596/Session-13-Benefit-Risk-in-Decision-Making-Tile.jpg2021-06-17T13:24:53.000Z"c712896a129efb46b1fc0eeec726f0ed"45534STANDARDArchive/19002/7639596/Session-13-Benefit-Risk-in-Decision-Making-captions.vtt2021-06-17T13:24:53.000Z"fee1ab7fd9008bf0d95860b197e43de5"97802eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639596/Session-13-Benefit-Risk-in-Decision-Making.jpg2021-06-17T13:24:53.000Z"1d6b4ae48a8937b59f010e067b1f38af"372327STANDARDArchive/19002/7639596/Session-13-Benefit-Risk-in-Decision-Making.mp42021-06-17T13:24:54.000Z"9e0dc441fd693bba7aa6481010f01d4a-8"123474146STANDARDArchive/19002/7639598/2021-06-17T13:24:53.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19002/7639598/14.1_19002_Long.pdf2021-06-17T13:24:53.000Z"85394dcd374cb603fb55d1877710de32"864147STANDARDArchive/19002/7639598/14.2_19002_Foy.pdf2021-06-17T13:24:53.000Z"b9227387ef37f3913a983801d12bc419"449461STANDARDArchive/19002/7639598/Session-14-Hot-Topics-Audio.m4a2021-06-17T13:24:54.000Z"c87873e2fc64f36521cfd50d22126fc7-6"92310062eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639598/Session-14-Hot-Topics-Tile.jpg2021-06-17T13:24:53.000Z"dff8b29194bb9db9bc9589d524a9220d"130812STANDARDArchive/19002/7639598/Session-14-Hot-Topics-captions.vtt2021-06-17T13:24:53.000Z"a12aa0ea992004c00768f12300edd579"98356eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639598/Session-14-Hot-Topics.jpg2021-06-17T13:24:53.000Z"5c5d6e362ab54abfeb4add1606a74f7a"649663eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639598/Session-14-Hot-Topics.mp42021-06-17T13:24:54.000Z"0d9d2abe60132d6bb801f4b1ac43a643-8"122128227STANDARDArchive/19002/7639604/2021-06-17T13:24:53.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19002/7639604/11.1_19002_Bracco.v2.pdf2021-06-17T13:24:53.000Z"31650d64ab6b07f0cdd223d4ce7043fc"1078831STANDARDArchive/19002/7639604/11.2_19002_Thompson.v2.pdf2021-06-17T13:24:53.000Z"aeb8f4db4c4d6ee4a4e5ee858793a4fe"200332STANDARDArchive/19002/7639604/11.3_19002_Ward.v2.pdf2021-06-17T13:24:53.000Z"10febf21f668802b3d91c02441bae773"560736STANDARDArchive/19002/7639604/Session-11-Safety-Considerations-for-Combination-Therapies-Part-1-Audio.m4a2021-06-17T13:24:54.000Z"efe6c7a23a1cb3d8875041e6ad89c395-6"92782972eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639604/Session-11-Safety-Considerations-for-Combination-Therapies-Part-1-Tile.jpg2021-06-17T13:24:53.000Z"5c3459bde5e7d0f9a0fddaf206003f06"138210STANDARDArchive/19002/7639604/Session-11-Safety-Considerations-for-Combination-Therapies-Part-1-captions.vtt2021-06-17T13:24:53.000Z"1e3d67ab150fadafaacbcc8caca196ae"90305eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19002/7639604/Session-11-Safety-Considerations-for-Combination-Therapies-Part-1-chapters.vtt2021-06-17T13:24:53.000Z"cad3f451416dbcde16267fae5d60d9ac"42STANDARDArchive/19002/7639604/Session-11-Safety-Considerations-for-Combination-Therapies-Part-1.jpg2021-06-17T13:24:53.000Z"01a31ebd9f92814a706b5ed25ab06889"644140STANDARDArchive/19002/7639604/Session-11-Safety-Considerations-for-Combination-Therapies-Part-1.mp42021-06-17T13:24:54.000Z"382546d25a850eef65bda48af34d22ac-7"113131933STANDARDArchive/19003/2021-06-17T13:24:52.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19004/2021-06-17T13:24:51.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19005/2021-06-17T13:24:51.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19005/Originals/2021-06-17T13:24:51.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19006/2021-06-17T13:24:50.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19007/2021-06-17T13:24:49.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19007/19007_01_190228-1.mp42021-06-17T13:24:50.000Z"15b2d557d5e9885a0caa13dd8fd60fe9-4"57251050STANDARDArchive/19007/19007_02_190228-2.mp42021-06-17T13:24:50.000Z"a4c84b41320909b31c00a95e935918bc-6"97115228STANDARDArchive/19007/19007_03_190228-3.mp42021-06-17T13:24:50.000Z"9de36e89273c9527360015b73d090161-7"111756115STANDARDArchive/19007/19007_04_190228-4.mp42021-06-17T13:24:50.000Z"45a61824743895f571738b3cee2eb5e0-6"96748989STANDARDArchive/19007/19007_05_190228-5.mp42021-06-17T13:24:50.000Z"5a1cfa3e117de7f2bab092f7ab8e7269-5"78022803STANDARDArchive/19007/19007_06_190228-6.mp42021-06-17T13:24:50.000Z"8d1a9081b12ebdcdac19647060c1d74e-7"106062640STANDARDArchive/19007/19007_07_190228-7.mp42021-06-17T13:24:50.000Z"0801e0991c3040a7001da1a959044ff9-8"130809557STANDARDArchive/19007/19007_08_190228-8.mp42021-06-17T13:24:50.000Z"5160bda56be95fdb1f59ee28ddc60c8e-4"63886184STANDARDArchive/19007/19007_09_190301-9.mp42021-06-17T13:24:50.000Z"afd52c2b319dc9d6ed0463656c6da2f3-3"36377068STANDARDArchive/19007/19007_10_A_190301-10.mp42021-06-17T13:24:50.000Z"60929a2de8d7f55e958bcec3d5eb951b-6"92208523STANDARDArchive/19007/19007_10_B_190301-11.mp42021-06-17T13:24:50.000Z"3f356279913235ef1940d8200ec31c42-7"106509198STANDARDArchive/19007/19007_11_A_190301-12.mp42021-06-17T13:24:50.000Z"d945d2a3636e273a7e34eb1a899b65b4-6"93712110STANDARDArchive/19007/19007_11_B_190301-13.mp42021-06-17T13:24:50.000Z"89436de353939cbefd72f689c157cea2-9"138258839STANDARDArchive/19007/19007_12_190301-14.mp42021-06-17T13:24:50.000Z"b792b35602ec9834ae55cdf57f0a09b3-7"107560374STANDARDArchive/19007/19007_13_190301-15.mp42021-06-17T13:24:50.000Z"949e8af2483acd1904e12ab41aa5fcab-6"92139654STANDARDArchive/19007/7730111/2021-06-17T13:24:49.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19007/7730111/02_Deborah Wolf.pdf2021-06-17T13:24:49.000Z"ba33bc4f083461041a3cddabe65058de"698814eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7730111/02_Elizabeth Pepinsky.pdf2021-06-17T13:24:49.000Z"e8293852ee81b1bd797602c6b1df8423"462200eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7730111/02_Lisa Stockbridge.pdf2021-06-17T13:24:49.000Z"b1e1216750e0959b0d1f3bceafbd56ae"632807eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7730111/02_Thomas Abrams.pdf2021-06-17T13:24:49.000Z"b9ac267398347412f96e51415236ce2e"519680STANDARDArchive/19007/7730111/session-2-update-from-fda-Tile.jpg2021-06-17T13:24:49.000Z"a353ca599a5dd25271b99494f9829f85"68559STANDARDArchive/19007/7730111/session-2-update-from-fda.jpg2021-06-17T13:24:49.000Z"be65a69073803be27704c3394d09a3dd"39633STANDARDArchive/19007/7730111/session-2-update-from-fda.mp42021-06-17T13:24:50.000Z"a4c84b41320909b31c00a95e935918bc-6"97115228STANDARDArchive/19007/7730114/2021-06-17T13:24:49.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19007/7730114/session-1-keynote-address-Tile.jpg2021-06-17T13:24:49.000Z"9c111a0c91f3d40695158f75265437f5"73308STANDARDArchive/19007/7730114/session-1-keynote-address.jpg2021-06-17T13:24:49.000Z"60f179c1f09eecf3a740ad7c4f9f2ccf"36917STANDARDArchive/19007/7730114/session-1-keynote-address.mp42021-06-17T13:24:50.000Z"15b2d557d5e9885a0caa13dd8fd60fe9-4"57251050STANDARDArchive/19007/7730313/session-4-industry-implementation-of-the-consistency-with-labeling-guidance-Tile.jpg2021-06-17T13:24:49.000Z"73de65d12423d7511d47fd0daa0ae52a"58508STANDARDArchive/19007/7730313/session-4-industry-implementation-of-the-consistency-with-labeling-guidance.jpg2021-06-17T13:24:49.000Z"2389432761b059c8153ad4cbd8279e3f"46154STANDARDArchive/19007/7730313/session-4-industry-implementation-of-the-consistency-with-labeling-guidance.mp42021-06-17T13:24:50.000Z"45a61824743895f571738b3cee2eb5e0-6"96748989STANDARDArchive/19007/7730315/session-3-demystifying-the-world-of-social-and-digital-media-Tile.jpg2021-06-17T13:24:49.000Z"17df70e15324e1ce061e55c28fdabad9"68442STANDARDArchive/19007/7730315/session-3-demystifying-the-world-of-social-and-digital-media.jpg2021-06-17T13:24:49.000Z"95be9c0515edf0a0c5091f27936a2a97"39684STANDARDArchive/19007/7730315/session-3-demystifying-the-world-of-social-and-digital-media.mp42021-06-17T13:24:50.000Z"9de36e89273c9527360015b73d090161-7"111756115STANDARDArchive/19007/7730317/session-7-current-policy-efforts-pharma-perspectives-on-maintaining-compliance-amidst-dramatic-environmentall-changes.mp42021-06-17T13:24:50.000Z"0801e0991c3040a7001da1a959044ff9-8"130809557STANDARDArchive/19007/7730319/session-5-building-quality-into-effective-implementation-of-communications-with-payers.mp42021-06-17T13:24:50.000Z"5a1cfa3e117de7f2bab092f7ab8e7269-5"78022803eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7730322/session-8-networking-for-professional-development-and-growth.mp42021-06-17T13:24:50.000Z"5160bda56be95fdb1f59ee28ddc60c8e-4"63886184eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7730377/session-12-building-bridges-creating-and-maintaining-a-productive-relationship-with-fda-on-advertising-and-promotion-issues.mp42021-06-17T13:24:50.000Z"b792b35602ec9834ae55cdf57f0a09b3-7"107560374eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7730379/session-13-delivering-relevant-information-to-the-customer-in-the-age-of-digital.mp42021-06-17T13:24:50.000Z"949e8af2483acd1904e12ab41aa5fcab-6"92139654eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7730388/session-11-track-a-interactions-with-patient-advocacy-groups.mp42021-06-17T13:24:50.000Z"89436de353939cbefd72f689c157cea2-9"138258839eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7730390/session-10-track-a-promotional-review-of-medical-developed-communications.mp42021-06-17T13:24:50.000Z"60929a2de8d7f55e958bcec3d5eb951b-6"92208523eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7730407/session-10-track-b-a-practical-look-at-legal-and-regulatory-issues-in-promoting-diagnostics-and-related-products.mp42021-06-17T13:24:50.000Z"3f356279913235ef1940d8200ec31c42-7"106509198eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7730409/session-11-sessions-track-b-pre-approval-activities-how-much-information-is-too-much.mp42021-06-17T13:24:50.000Z"d945d2a3636e273a7e34eb1a899b65b4-6"93712110eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7822243/session-6-opdp-research-agenda-update.mp42021-06-17T13:24:50.000Z"8d1a9081b12ebdcdac19647060c1d74e-7"106062640eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19007/7823373/session-9-keynote-address.mp42021-06-17T13:24:50.000Z"afd52c2b319dc9d6ed0463656c6da2f3-3"36377068eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19008/2021-06-17T13:24:49.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19011/2021-06-17T13:24:48.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19012/2021-06-17T13:24:48.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19014/2021-06-17T13:24:48.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19018/2021-06-17T13:24:47.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19018/19018_0001_Keynote-1.mp42021-06-17T13:24:47.000Z"484b6d62c0af93c3bca78f4c322e5c53-11"181632895STANDARDArchive/19018/19018_0002_041119-2.mp42021-06-17T13:24:47.000Z"5091a97d39f2b7c3ff172faf15b4f120-10"156740589STANDARDArchive/19018/19018_0003_041119-3.mp42021-06-17T13:24:47.000Z"00df070e05b08918689ea19232837342-3"39394280STANDARDArchive/19018/19018_0004_041119-4.mp42021-06-17T13:24:47.000Z"5af706d7f27b9fe9bac520746dd49098-8"127144883STANDARDArchive/19018/19018_0005_041119-5.mp42021-06-17T13:24:47.000Z"c5adf119e890a88ec6afe02ab8f763e3-12"194329251STANDARDArchive/19018/19018_0006_041119-6.mp42021-06-17T13:24:47.000Z"31b780239ee5a1176f36d9c2ad8db4f6-8"117972599STANDARDArchive/19018/19018_Welcome-1.mp42021-06-17T13:24:47.000Z"b3282deba546af8f224df8c8fe541ba3-2"24888158STANDARDArchive/19018/7639831/2021-06-17T13:24:47.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19018/7639835/2021-06-17T13:24:47.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19018/7860355/2021-06-17T13:24:47.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19018/8247112/2021-06-17T13:24:47.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19018/8247112/1_19018_Ball_final.pdf2021-06-17T13:24:47.000Z"32d8586e7b16fb801fbf0c13329d8318"3366164STANDARDArchive/19018/8247112/1_19018_Foy.pdf2021-06-17T13:24:47.000Z"d0f24556e63cc1ddeb74972dd87c8e1f"1472797STANDARDArchive/19018/8247112/1_19018_Mes_Final.pdf2021-06-17T13:24:47.000Z"9983619697ce148ee1ec7927b719d2f2"493568STANDARDArchive/19018/8247112/Session-1-What-s-New-and-What-s-Hot-Perspective-on-Pharmacovigilance-and-Risk-Management-A-Global-Perspective-Audio.m4a2021-06-17T13:24:47.000Z"72f779bedb62bf84898c03c77be423a3-6"95361271eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19018/8247112/Session-1-What-s-New-and-What-s-Hot-Perspective-on-Pharmacovigilance-and-Risk-Management-A-Global-Perspective-Tile.jpg2021-06-17T13:24:47.000Z"a2b255422501e358317b063fdc3e6327"71570STANDARDArchive/19018/8247112/Session-1-What-s-New-and-What-s-Hot-Perspective-on-Pharmacovigilance-and-Risk-Management-A-Global-Perspective-captions.vtt2021-06-17T13:24:47.000Z"a12aa0ea992004c00768f12300edd579"98356eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19018/8247112/Session-1-What-s-New-and-What-s-Hot-Perspective-on-Pharmacovigilance-and-Risk-Management-A-Global-Perspective.jpg2021-06-17T13:24:47.000Z"7822ac4721a2958b864db04d736d01c1"440473STANDARDArchive/19018/8247112/Session-1-What-s-New-and-What-s-Hot-Perspective-on-Pharmacovigilance-and-Risk-Management-A-Global-Perspective.mp42021-06-17T13:24:47.000Z"484b6d62c0af93c3bca78f4c322e5c53-11"181632895STANDARDArchive/19018/8247130/2021-06-17T13:24:47.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19018/8247130/4_19018_Fannie St-Gelais-Literature.pdf2021-06-17T13:24:47.000Z"d68e927d24777937c868b02e58422686"180498STANDARDArchive/19018/8247130/4_19018_Fannie St-Gelais.pdf2021-06-17T13:24:47.000Z"39b693d31e70e1b272799cdb558f1480"337316STANDARDArchive/19018/8247130/4_19018_Jokinen.pdf2021-06-17T13:24:47.000Z"2bb4b06e50ef4de865696c2fe8fd099f"968933STANDARDArchive/19018/8247130/Session-4-Clinical-Development-Pharmacovigilance-vs-Post-Marketing-Pharmacovigilance-Comparison-Audio.m4a2021-06-17T13:24:47.000Z"c4cf77dc3e0aee59fda5d1daca32b108-6"95104317eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19018/8247130/Session-4-Clinical-Development-Pharmacovigilance-vs-Post-Marketing-Pharmacovigilance-Comparison-Tile.jpg2021-06-17T13:24:47.000Z"6af7166ccc24e90238513e7160982d31"47600STANDARDArchive/19018/8247130/Session-4-Clinical-Development-Pharmacovigilance-vs-Post-Marketing-Pharmacovigilance-Comparison-captions.vtt2021-06-17T13:24:47.000Z"ebf21b251ebc0bbf22ab5697333e094e"96270eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19018/8247130/Session-4-Clinical-Development-Pharmacovigilance-vs-Post-Marketing-Pharmacovigilance-Comparison.jpg2021-06-17T13:24:47.000Z"099cabd564cd755b15e6f9a88ec7bd69"365346STANDARDArchive/19018/8247130/Session-4-Clinical-Development-Pharmacovigilance-vs-Post-Marketing-Pharmacovigilance-Comparison.mp42021-06-17T13:24:47.000Z"5af706d7f27b9fe9bac520746dd49098-8"127144883STANDARDArchive/19020/2021-06-17T18:26:35.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19036/2021-06-17T18:26:33.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19037/2021-06-17T18:26:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19101/2021-06-17T18:26:28.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19101/19101_CD1_2019-02-07_1515_F2_40240_EDITED.mp42021-06-17T18:26:28.000Z"addc7580433a8da4b083f1687b74784b-42"688224478STANDARDArchive/19101/19101_DMD01_2019-02-05_1100_Hall_D_40186_EDITED.mp42021-06-17T18:26:28.000Z"62a0cddb09ec76ad56920ebccbd0d5aa-46"769483146STANDARDArchive/19101/19101_DMD03_2019-02-05_1400_E1_40188_EDITED.mp42021-06-17T18:26:28.000Z"01eeef0ddc5720558cddb9bb789f43fd-47"778855152STANDARDArchive/19101/19101_DMD04_2019-02-05_1400_E2_40189_EDITED.mp42021-06-17T18:26:28.000Z"da4f621db19318edb46252dbd451962c-75"1254303407STANDARDArchive/19101/19101_DMD05_2019-02-05_1600_Hall_D_40190_EDITED.mp42021-06-17T18:26:28.000Z"a288ded706a0f8732714ece206369ece-11"182149372STANDARDArchive/19101/19101_DMD06_2019-02-05_1100_E1_40191_EDITED.mp42021-06-17T18:26:28.000Z"ffb5ac48a15fd93efb7dc553a2baf758-31"510596533STANDARDArchive/19101/19101_DMD07_2019-02-06_0915_E1_40192_EDITED.mp42021-06-17T18:26:28.000Z"f735315064b476015780b17f9d53400c-42"700980524STANDARDArchive/19101/19101_DMD08_2019-02-06_0915_E2_40193_EDITED.mp42021-06-17T18:26:28.000Z"fee71705c54b3613787b3c52b4b5f655-19"315951124STANDARDArchive/19101/19101_DMD09_2019-02-06_0915_F1_40194_EDITED.mp42021-06-17T18:26:28.000Z"08b8a3a62229b7372e7ec930ca165136-40"655534438STANDARDArchive/19101/19101_DMD10_2019-02-07_1400_E2_40213_EDITED.mp42021-06-17T18:26:28.000Z"7feb0313a80adda42f5847e14d354af3-27"440054669STANDARDArchive/19101/19101_DMD11_2019-02-07_1400_F1_40214_EDITED.mp42021-06-17T18:26:28.000Z"3bc0914bce123bc2f308a7e515be2dc1-34"565452348STANDARDArchive/19101/19101_KN2_2019-02-06_EDITED.mp42021-06-17T18:26:28.000Z"67acafd8532228b66b0fb2353895f6b2-23"374078967STANDARDArchive/19101/19101_KN3_2019-02-07_0830_E1_40205_EDITED.mp42021-06-17T18:26:28.000Z"3a8b9b1f7b71cfd9994ff562fe975375-16"256625775STANDARDArchive/19101/19101_LOT01_2019-02-05_1600_F2_40317_EDITED.mp42021-06-17T18:26:28.000Z"103de8a1d9e06d4e4926fe4dd06eb90e-40"670636073STANDARDArchive/19101/19101_LS01_2019-02-06_1330_Dialogue_Space_40239_EDITED.mp42021-06-17T18:26:28.000Z"26b78d28ae24817066b6dc9db3ef052d-11"175021742STANDARDArchive/19101/19101_S0101_2019-02-06_1045_E1_40144_EDITED.mp42021-06-17T18:26:28.000Z"3a276055723eeed64b9d31f4593ea709-24"386566275STANDARDArchive/19101/19101_S0102_2019-02-06_1200_E1_40145_EDITED.mp42021-06-17T18:26:28.000Z"49658c1cdaaf3d003dd03d9c76c670db-73"1218484338STANDARDArchive/19101/19101_S0103_2019-02-06_1515_E1_40146_EDITED.mp42021-06-17T18:26:28.000Z"2a12db2a52f323a6370e3753a9f34cd0-50"823567938STANDARDArchive/19101/19101_S0104_2019-02-06_1645_Dialogue_Space_40147_EDITED.mp42021-06-17T18:26:28.000Z"bb924a226144fd4a81c7c90a2ace9531-57"953005433STANDARDArchive/19101/19101_S0105 _2019-02-07_0915_E1_40148_EDITED.mp42021-06-17T18:26:28.000Z"b4fc853c5522f15ec161689754ab1388-37"611225574STANDARDArchive/19101/19101_S0106_2019-02-07_1045_E1_40149_EDITED.mp42021-06-17T18:26:28.000Z"cf773aede1215d0429742c9c23cc6333-25"418434391STANDARDArchive/19101/19101_S0107_2019-02-07_1200_E1_40150_EDITED.mp42021-06-17T18:26:28.000Z"3e622c22a76c0e56ff64f4d48e4587c1-44"725098204STANDARDArchive/19101/19101_S0201_2019-02-06_1045_G1_40151_EDIT.mp42021-06-17T18:26:28.000Z"fcaa0e12ef879ae22623ab0fbf45fb3a-34"569375187STANDARDArchive/19101/19101_S0202_2019-02-06_1200_F2_40152_EDITED.mp42021-06-17T18:26:29.000Z"be6fb4ac471ca76d6b3bf05cd397d961-40"656529010STANDARDArchive/19101/19101_S0203_2019-02-06 _515_K2_40153_EDITED.mp42021-06-17T18:26:28.000Z"9020dd9db974ffc86c5739917ff16e57-28"456435238STANDARDArchive/19101/19101_S0204_2019-02-06_1645_G1_40154EDITED.mp42021-06-17T18:26:28.000Z"ae848436e4df9b5208268c07c6248c7c-39"643508763STANDARDArchive/19101/19101_S0205_2019-02-07_0915_G1_40155_EDITED.mp42021-06-17T18:26:28.000Z"1f4f93e155db9711396725aef7c2a202-42"690795737STANDARDArchive/19101/19101_S0206_2019-02-07_1045_G1_S0206_40156_EDITED.mp42021-06-17T18:26:28.000Z"b6ef1b84afd749ff001718400a5ab2d0-50"827948098STANDARDArchive/19101/19101_S0301_2019-02-06_1045_E2_40158_EDITED.mp42021-06-17T18:26:28.000Z"9efbae855a421a9586b9845d375b69ec-38"631083339STANDARDArchive/19101/19101_S0302_2019-02-06_1200_E2_40159_EDITED.mp42021-06-17T18:26:28.000Z"1d486659ac4dd817b780af3f909311e4-39"639068461STANDARDArchive/19101/19101_S0303_2019-02-06_1515_E2_40160_EDITED.mp42021-06-17T18:26:28.000Z"e5c67a5df6f30ec3a32e1d7d0fcb7e20-39"639750332STANDARDArchive/19101/19101_S0304_2019-02-06.mp42021-06-17T18:26:28.000Z"239bf24f81cf406c34c2ba8f0321364b-25"418988716STANDARDArchive/19101/19101_S0304_2019-02-06_1645_E2_40161_EDITED.mp42021-06-17T18:26:28.000Z"239bf24f81cf406c34c2ba8f0321364b-25"418988716STANDARDArchive/19101/19101_S0305_2019-02-07_0915_E2_40163_EDITED.mp42021-06-17T18:26:28.000Z"bcf1c47d5e156b9c2414ec4bb4fee8aa-22"366343170STANDARDArchive/19101/19101_S0306_2019-02-07_1045_E2_40164_EDITED.mp42021-06-17T18:26:28.000Z"dad245ef33003f9a2c8b319f6ded4477-38"620920896STANDARDArchive/19101/19101_S0307_2019-02-07_1200_E2_40165_EDITED.mp42021-06-17T18:26:29.000Z"260b8b33a226e3e1780d58feb7fc2002-34"565811284STANDARDArchive/19101/19101_S0401_2019-02-06_1045_Dialogue_ 40166_EDITED.mp42021-06-17T18:26:28.000Z"d3ff6c48687ab19d672fc14eb363d74b-32"532717277STANDARDArchive/19101/19101_S0402 2019-02-06_1200 _F1_40167_EDIT.mp42021-06-17T18:26:28.000Z"37cd4934e133c1d2838bc742d4ba2164-43"708367026STANDARDArchive/19101/19101_S0403 2019-02-06_1515_F1_40168_EDITED.mp42021-06-17T18:26:28.000Z"5280631682ca811c63b752f0ed1fadd3-44"721850695STANDARDArchive/19101/19101_S0404_2019-02-06_1645_F_40169_EDIT.mp42021-06-17T18:26:28.000Z"ac4c5f3b55508431e7c82d2342e5105d-35"574858610STANDARDArchive/19101/19101_S0405_2019-02-07_0915 _F1_40170_EDITED.mp42021-06-17T18:26:29.000Z"c892b4625bfa2fcc81da7203c4a32f1b-31"509898978STANDARDArchive/19101/19101_S0406_2019-02-07_1045_F1_40171_EDITED.mp42021-06-17T18:26:29.000Z"2c5b6d3261f3005a20013c0b6f318af2-43"714488809STANDARDArchive/19101/19101_S0407_2019-02-07_1200_Dialogue_40172_EDITED.mp42021-06-17T18:26:29.000Z"fbdb69bd24441af9a4d9a42ea539d8f2-31"504401348STANDARDArchive/19101/19101_S0501_2019-02-06_1045_G2_40196_EDITED.mp42021-06-17T18:26:29.000Z"530e5721a8735cd28d64d940197765dc-28"461095555STANDARDArchive/19101/19101_S0502_2019-02-06_1200_G2_40197_EDITED.mp42021-06-17T18:26:29.000Z"fbda90d6d562fa63e413fd9e9f960d04-49"805556631STANDARDArchive/19101/19101_S0503_2019-02-06_1515_G2_40198_EDITED.mp42021-06-17T18:26:29.000Z"f7ffddfb856408ab2286f8cc004a40f9-30"489888848STANDARDArchive/19101/19101_S0504_2019-02-06_1645_G2_40199_EDITED.mp42021-06-17T18:26:29.000Z"3a1b500babc9ab029456828342695480-66"1097212927STANDARDArchive/19101/19101_S0505_2019-02-07_0915_G2_40200_EDITED.mp42021-06-17T18:26:29.000Z"66263679d8ca5be32f76a1a87534331d-39"644111448STANDARDArchive/19101/19101_S0507_2019-02-07_1200_G2_40217_EDITED.mp42021-06-17T18:26:29.000Z"5320f6529457b68cb46228dab027f800-16"254292146STANDARDArchive/19101/19101_S0601_2019-02-06_1045_K1_40173_EDITED.mp42021-06-17T18:26:29.000Z"fcace83aa70279146376bbc92ad0f4e5-27"447599410STANDARDArchive/19101/19101_S0602_2019-02-06_1200_K1_40174_EDITED.mp42021-06-17T18:26:29.000Z"559153516d287619bc3fb0b2d0618103-42"697503031STANDARDArchive/19101/19101_S0603_2019-02-06_1515_K1_4017_ EDITED.mp42021-06-17T18:26:29.000Z"979148d629e55f084e10c26bd095f61a-8"127572261STANDARDArchive/19101/19101_S0604_2019-02-0_1645_K1_40176_EDITED.mp42021-06-17T18:26:29.000Z"1b40f90e5540d21b3690556910908c0f-19"315486562STANDARDArchive/19101/19101_S0605_2019-02-07_0915_DIAlogue_Space_41314_EDITED.mp42021-06-17T18:26:29.000Z"8e8b5838ee2ca7cd4beda99813fbfc0e-38"635070563STANDARDArchive/19101/19101_S0606_2019-02-07_1045_Dialogue_Space_40177_EDITED.mp42021-06-17T18:26:29.000Z"2891aeac82544f0f78ad7331899c39de-12"193841039STANDARDArchive/19101/19101_S0607_2019-02-07_1200_G1_40178_EDITED.mp42021-06-17T18:26:29.000Z"83e3a7017689f07ffa98c106651a82e8-24"387759533STANDARDArchive/19101/19101_S0701_2019-02-06_1045_F2_40179_EDITED.mp42021-06-17T18:26:29.000Z"771bb14d6cf3e4f0fe1c547f000a7e0b-34"569812155STANDARDArchive/19101/19101_S0702_2019-02-06_1200_Dialogue_40180_EDITED.mp42021-06-17T18:26:29.000Z"4d8b190be08ff0c72585dffb53fb26f5-52"859614350STANDARDArchive/19101/19101_S0703_2019-02-06_1515_F2_40181_EDITED.mp42021-06-17T18:26:29.000Z"147fd9f6a3660034e48c1efbe82807c5-38"635333518STANDARDArchive/19101/19101_S0704_2019-02-06_1645_F2_40182_EDITED.mp42021-06-17T18:26:29.000Z"15e545178294bc23d3caaa448b06c9a0-37"606583476STANDARDArchive/19101/19101_S0705_2019-02-07_0915_F2_40183_EDITED.mp42021-06-17T18:26:30.000Z"fa9cb2e469ea939a6c7490f1f085c32b-29"477531111STANDARDArchive/19101/19101_S0706_2019-02-07_1045_F2_40184_EDITED.mp42021-06-17T18:26:30.000Z"5fc22325dcebba10f3fe0f8511c62542-28"455211005STANDARDArchive/19101/19101_S0707_2019-02-07_1200_F2_40201_EDITED.mp42021-06-17T18:26:30.000Z"89a6fe2e74af385740e6bff5b049444d-23"385803437STANDARDArchive/19101/19101_S0801_2019-02-06_1045_K2_40195_EDITED.mp42021-06-17T18:26:30.000Z"a3353a8e06cef1537813bc14cecc666c-35"583159983STANDARDArchive/19101/19101_S0802_2019-02-06_1200_K2_40314_EDITED.mp42021-06-17T18:26:30.000Z"69858b6b6915571281e3a5d083f11eef-45"738628332STANDARDArchive/19101/19101_S0803_2019-02-06_1515_G1_40316_EDITED.mp42021-06-17T18:26:30.000Z"8dc38fb7ddfde50408bc99b0efe00981-31"505478430STANDARDArchive/19101/19101_S0804_2019-02-06_1645_K2_40203_EDITED.mp42021-06-17T18:26:30.000Z"df73cf8ec78ddbb4d5a56551b52c5cfa-65"1088941218STANDARDArchive/19101/19101_S0805_2019-02-07_0915_K2_40207_EDITED.mp42021-06-17T18:26:30.000Z"c8abefc79b4a2735fc877681731c049d-46"760594294STANDARDArchive/19101/19101_S0806_2019-02-07_1045_K2_40185_EDITED.mp42021-06-17T18:26:30.000Z"852b0d586a5f9af941a935ec21f5bd14-59"973801340STANDARDArchive/19101/19101_S0807_2019-02-07_1200_K2_4021_ EDITED.mp42021-06-17T18:26:30.000Z"89188969fb084d12d06ed2e1f7548757-15"236064347STANDARDArchive/19101/19101_S0901_2019-02-06_1045_F1_40206_EDITED.mp42021-06-17T18:26:30.000Z"aea5ca96df30a623059722e3aa59193e-53"878780990STANDARDArchive/19101/19101_S0902_2019-02-06_1200_G1_40220_EDITED.mp42021-06-17T18:26:30.000Z"06356c8452477d62487225b483232049-23"373396141STANDARDArchive/19101/19101_S0903_2019-02-06_1515_Dialogue_Space_40216_EDITED.mp42021-06-17T18:26:30.000Z"dc1e5803a3b7b16b751014133efd95ff-32"523227156STANDARDArchive/19101/19101_S0904_2019-02-06_1645_E1_40221_EDITED.mp42021-06-17T18:26:30.000Z"66947682137ea767836b424cf9183acf-50"835929379STANDARDArchive/19101/19101_S0905_2019-02-07_0915_K1_40243_EDITED.mp42021-06-17T18:26:30.000Z"f56734c3a95a142ca92e1e1da0e5e045-28"460178971STANDARDArchive/19101/19101_S0906 - ICH - Wendy Zwolenski-Lambert - 2019-02-07 1045 K1 40218 EDITED.mp42021-06-17T18:26:30.000Z"1370935c08670754dd9c4b6d3c3b0fe9-12"191063046STANDARDArchive/19101/19101_S0906-ICH-Full session_1_-2019-02-07_1045_K1_40218_EDITED.mp42021-06-17T18:26:30.000Z"2d9b1e52df108059fd14c5ade327e396-25"408749069STANDARDArchive/19101/19101_S0906-ICH-Lenita_Lindström-Gommers-2019-02-07_1045_K1_40218_EDITED.mp42021-06-17T18:26:30.000Z"8fcda0ad97721b84ff680aea5ddb5b18-13"205990529STANDARDArchive/19101/19101_S0907-ICH-Tania_Cecilia_Cavaliero_2019-02-07_1200_K1_40219_EDITED.mp42021-06-17T18:26:30.000Z"1c3794f1b043b0658ce698f2a637ade7-24"395359453STANDARDArchive/19101/19101_S0907_ICH_Fergus_Sweeney_2019-02-07_1200_ K1_40219_EDITED.mp42021-06-17T18:26:30.000Z"241ae3a7f0886346ac7c0f10fca9d545-16"262873263STANDARDArchive/19101/19101_S0907_ICH_Full_Session_2_2019-02-07_1200_K1_40219_EDITED.mp42021-06-17T18:26:30.000Z"7f2e65be2c5528c74621e4c022cfd974-46"765604463STANDARDArchive/19101/19101_SAT1_2019-02-05_1400_Dialogue_Space_40315_EDITED.mp42021-06-17T18:26:30.000Z"16f5133a8a37ba5c27d378e2712cb453-32"532469695STANDARDArchive/19101/19101_WL01_2019-02-05_1600_Dialogue_Space_41360_EDITED.mp42021-06-17T18:26:31.000Z"9a993acf4aa35ac8ee85e154fffc7e80-24"395927227STANDARDArchive/19101/1910_ KN1_2019-02-05_1000_EDITED.mp42021-06-17T18:26:30.000Z"397f934030535ef2a13109876dae0faf-7"108205011STANDARDArchive/19101/7639554/2021-06-17T18:26:28.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19101/7639554/Session-1-FDA-Updates-Audio.m4a2021-06-17T18:26:28.000Z"79bd5f405baaf42e595b686ab067a190"10654346eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19101/7639554/Session-1-FDA-Updates-captions.vtt2021-06-17T18:26:28.000Z"a6e90922499b43cd94e3de1b9628b2cc"102440eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19101/7639554/Session-1-FDA-Updates.jpg2021-06-17T18:26:28.000Z"fc21b76c4b3b8ae281f1a7489a4fc5ae"655762eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19101/7639831/2021-06-17T18:26:28.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19101/7639831/Forum-on-Global-Pharmacovigilance-Tile.jpg2021-06-17T18:26:28.000Z"6e2cc6fa32f95a670b89ec3df6065cf3"109238STANDARDArchive/19101/7639831/Forum-on-Global-Pharmacovigilance.jpg2021-06-17T18:26:28.000Z"d1b88a971420fafc9756ecb31fa124d3"778317STANDARDArchive/19101/7639831/S0302_Pal.pdf2021-06-17T18:26:28.000Z"b60c4da18dc93fa9503f65ee8452c382"2402196STANDARDArchive/19101/7639831/S0302_Vachhani.pdf2021-06-17T18:26:28.000Z"25e53a15354e26d72f643c49685e4663"1279939STANDARDArchive/19101/7639831/S0302_vanderElst.pdf2021-06-17T18:26:28.000Z"afdfd389f5cdb9a5f9a7c2bea7154fed"833741STANDARDArchive/19101/7639835/2021-06-17T18:26:28.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19101/7639835/S0303_Littlebury.pdf2021-06-17T18:26:28.000Z"865ec530b1ea5bbe7a36381f7ce4fead"2697081STANDARDArchive/19101/7639835/S0303_Michel.pdf2021-06-17T18:26:28.000Z"488b407c647790216c63a63219f89f9a"1445298STANDARDArchive/19101/7639835/S0303_Walters.pdf2021-06-17T18:26:28.000Z"caaa8e6984e70732f92060a3f63395e2"1189637STANDARDArchive/19101/7639835/The-New-EudraVigilance-System-One-Year-After-Audio.m4a2021-06-17T18:26:30.000Z"e3f9caec8a92195e9db079e8be8794f3-6"100376927eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19101/7639835/The-New-EudraVigilance-System-One-Year-After-Tile.jpg2021-06-17T18:26:28.000Z"ed7c1b925bf260efcd15aceb57103b69"45008STANDARDArchive/19101/7639835/The-New-EudraVigilance-System-One-Year-After-captions.vtt2021-06-17T18:26:28.000Z"871af7d2bb6e2f702502ca9a4e9452d2"90017eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19101/7639835/The-New-EudraVigilance-System-One-Year-After.jpg2021-06-17T18:26:28.000Z"f0dfd46d977d21661f3e6df3b9651f9c"432682eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19101/7639835/asia-region-updates.jpg2021-06-17T18:26:28.000Z"2bb8e2ec4a684112a1c5551720f2daf3"568259STANDARDArchive/19102/2021-06-17T18:26:27.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19104/2021-06-17T18:26:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19104/19104_01_061119-1.mp42021-06-17T18:26:27.000Z"0cb24a3ba9d9419bdc3b29a21dfa346b-14"223578217STANDARDArchive/19104/19104_02_061119-2.mp42021-06-17T18:26:27.000Z"6785e656638f97f7b439a4e2db904720-13"207650265STANDARDArchive/19104/19104_03_06119-1.mp42021-06-17T18:26:27.000Z"e20b46c7ed534ebf2aa6d10a671d3d74-13"217943669STANDARDArchive/19104/19104_04_061119-1.mp42021-06-17T18:26:27.000Z"1c1b8b7c3925f59cb531835072d5380a-13"217383319STANDARDArchive/19104/19104_05_071119-1.mp42021-06-17T18:26:27.000Z"064d1a78cce9780617878cd1292aa6b6-13"208722169STANDARDArchive/19104/19104_06_071119-1.mp42021-06-17T18:26:27.000Z"7880eb12fb05bcd406883424ef5b3c87-13"212631393STANDARDArchive/19104/19104_0_071119-3.mp42021-06-17T18:26:27.000Z"3f0ed510bb7ee01db494fd305fdd7e9d-18"293951170STANDARDArchive/19104/8030694/2021-06-17T18:26:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19104/8030694/S1.0_Doris.pdf2021-06-17T18:26:26.000Z"fb1235aca430dd53b64d33276003f1b0"76295STANDARDArchive/19104/8030694/S1.1_Peter.pdf2021-06-17T18:26:27.000Z"ba3956e429cd2d1aa7ef07b426571607"177671STANDARDArchive/19104/8030694/S1.2_Sabine.pdf2021-06-17T18:26:26.000Z"20d9af79f43ca24cb86646fc3b50e619"3464515STANDARDArchive/19104/8030694/S1.3_Shanthi.pdf2021-06-17T18:26:26.000Z"9bdd0f6f84bf135b3dc16914f994342f"1958910STANDARDArchive/19104/8030694/Session-1-Future-of-Pharmacovigilance-Globalisation-Back-to-the-Future-Audio.m4a2021-06-17T18:26:27.000Z"b51dc2977998d24c21c18fea6d421768-9"137190940eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19104/8030694/Session-1-Future-of-Pharmacovigilance-Globalisation-Back-to-the-Future-Tile.jpg2021-06-17T18:26:26.000Z"50adb0d5d0b820d81a38fb5ce6fd5755"58807STANDARDArchive/19104/8030694/Session-1-Future-of-Pharmacovigilance-Globalisation-Back-to-the-Future-captions.vtt2021-06-17T18:26:26.000Z"dba43f569b427db8ceb8f10196fa753f"125062eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19104/8030694/Session-1-Future-of-Pharmacovigilance-Globalisation-Back-to-the-Future.jpg2021-06-17T18:26:26.000Z"e385a636a99039f5b699ff1460b5501d"398787STANDARDArchive/19104/8030694/Session-1-Future-of-Pharmacovigilance-Globalisation-Back-to-the-Future.mp42021-06-17T18:26:27.000Z"0cb24a3ba9d9419bdc3b29a21dfa346b-14"223578217STANDARDArchive/19104/8030843/2021-06-17T18:26:27.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19104/8030843/S3.1_Kiernan.pdf2021-06-17T18:26:26.000Z"473ded9ebdb1eceb5f339696f552e61a"395719STANDARDArchive/19104/8030843/S3.2_Line.pdf2021-06-17T18:26:26.000Z"bcac30c9e8fecc142553413816df8c26"493351STANDARDArchive/19104/8030843/S3.3_Marouane.pdf2021-06-17T18:26:26.000Z"5e4a0c00a1490d1843b0ed810259259a"445625STANDARDArchive/19104/8030843/Session-3-Global-Perspective-Inspection-Audits-Audio.m4a2021-06-17T18:26:27.000Z"0850866619ec1c88634f58a8cca22854-9"145947808eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19104/8030843/Session-3-Global-Perspective-Inspection-Audits-Tile.jpg2021-06-17T18:26:26.000Z"422c373dec31f0d06e8eee09d5292a13"61257STANDARDArchive/19104/8030843/Session-3-Global-Perspective-Inspection-Audits-captions.vtt2021-06-17T18:26:26.000Z"31dcf1ab1f6680844fa99f38e0decd38"133622eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19104/8030843/Session-3-Global-Perspective-Inspection-Audits.jpg2021-06-17T18:26:27.000Z"168a89a9d15f66117cf3f4f13f9f9c6b"425911STANDARDArchive/19104/8030843/Session-3-Global-Perspective-Inspection-Audits.mp42021-06-17T18:26:27.000Z"e20b46c7ed534ebf2aa6d10a671d3d74-13"217943669STANDARDArchive/19104/8030865/2021-06-17T18:26:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19104/8030865/S4.1_Christopher.pdf2021-06-17T18:26:26.000Z"7d99915628f56dcc0b743fdd18bb562c"522769STANDARDArchive/19104/8030865/S4.2_Wendy.pdf2021-06-17T18:26:26.000Z"84d207cbcdc72171b8ef8de33afbd21d"539443STANDARDArchive/19104/8030865/S4.3_Joanne.pdf2021-06-17T18:26:26.000Z"063c58f0add459a3909a72989cce82f6"410868STANDARDArchive/19104/8030865/Session-4-QPPV-Oversight-and-Data-Integrity-Audio.m4a2021-06-17T18:26:27.000Z"23ce53fdfa26d903919a3d0a3e944c6e-8"130866110STANDARDArchive/19104/8030865/Session-4-QPPV-Oversight-and-Data-Integrity-Tile.jpg2021-06-17T18:26:26.000Z"3c9cb56c15bd16b6b566eb8a3d7eef44"64813STANDARDArchive/19104/8030865/Session-4-QPPV-Oversight-and-Data-Integrity.jpg2021-06-17T18:26:26.000Z"9d201b74152f3056930c3841b3d7b312"438869STANDARDArchive/19104/8030865/Session-4-QPPV-Oversight-and-Data-Integrity.mp42021-06-17T18:26:27.000Z"1c1b8b7c3925f59cb531835072d5380a-13"217383319STANDARDArchive/19104/8030902/2021-06-17T18:26:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19104/8030902/S5.1_Achint.pdf2021-06-17T18:26:26.000Z"c98c9f5d43959948f29351d564ea6c09"352688STANDARDArchive/19104/8030902/S5.2_Frederic.pdf2021-06-17T18:26:26.000Z"ce8f3d93102bab80975c5e01b49b386f"1632873STANDARDArchive/19104/8030902/S5.3_Magnus.pdf2021-06-17T18:26:26.000Z"7a4c3bc1c689a06e6ebcd236206c6047"748152STANDARDArchive/19104/8030902/Session-5-Signalling-and-Risk-Management-Tile.jpg2021-06-17T18:26:26.000Z"e8690f40ea52e15378215d94f5bee894"50136STANDARDArchive/19104/8030902/Session-5-Signalling-and-Risk-Management.jpg2021-06-17T18:26:26.000Z"65aa02ea77aa0814800484023e21a5f6"359333STANDARDArchive/19104/8030902/Session-5-Signalling-and-Risk-Management.mp42021-06-17T18:26:27.000Z"064d1a78cce9780617878cd1292aa6b6-13"208722169STANDARDArchive/19104/8030902/session-5-signalling-and-risk-management-Audio.m4a2021-06-17T18:26:27.000Z"ff9022c3be5357e8b971db6ec4ee10c3-8"128782699eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19104/S7_19-11-07 13-58-36-1.mp42021-06-17T18:26:27.000Z"659151eebdfa2c38dc0dedec47081dbd-18"295541372STANDARDArchive/19107/2021-06-17T18:26:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19108/2021-06-17T18:26:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19108/19108_01_01-1.mp42021-06-17T18:26:26.000Z"79cd16e774117e8ac3ba1db6873ba6d9-8"122155917STANDARDArchive/19108/19108_01_02-1.mp42021-06-17T18:26:26.000Z"28d9560049a18492622c1f0f8a762609-9"136583038STANDARDArchive/19108/19108_01_03-1.mp42021-06-17T18:26:26.000Z"70201d837708b4be117074a54fa5f8df-7"107984027STANDARDArchive/19108/19108_02_06-1.mp42021-06-17T18:26:26.000Z"55a2544b34df65df58e30b8a198e32c1-6"86362858STANDARDArchive/19108/19108_Day1_Session1.mp42021-06-17T18:26:26.000Z"dcf802430c2ccf7f11531c0fe50d1218-8"127518998STANDARDArchive/19108/19108_Day1_Session2.mp42021-06-17T18:26:26.000Z"fd56ea1bfd0f66024a198063358c140a-9"141609499STANDARDArchive/19108/19108_Day1_Session3.mp42021-06-17T18:26:26.000Z"77a213a2364ab6a332581d82a2b9a527-7"115085513STANDARDArchive/19108/19108_Day1_Session4.mp42021-06-17T18:26:26.000Z"7b13aecbaf170bb1637352545adde257-6"99907824STANDARDArchive/19108/19108_Day2_Session5.mp42021-06-17T18:26:26.000Z"b3b04e3fa07090bec3d8637f735dd422-7"116836429STANDARDArchive/19108/19108_Day2_Session6.mp42021-06-17T18:26:26.000Z"d3d58dfd54d39368716eac618a702507-6"89480891STANDARDArchive/19108/7860355/2021-06-17T18:26:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19108/7860355/S1.1_KC - Case Studies on how GDPR has is Affecting Pharmacovigilance.pdf2021-06-17T18:26:25.000Z"bddc26f2415b0df0312e7c3799ed1400"522304STANDARDArchive/19108/7860355/S1.2_Yelkur - GDPR Application in PV.pdf2021-06-17T18:26:25.000Z"f34dbf7f3e74cc324354ed9ce326f40e"299396STANDARDArchive/19108/7860355/S1.3_Stenver - Data Privacy in Pharmacovigilance Context and Perspective.pdf2021-06-17T18:26:25.000Z"19fae1fdbe60639f920c74deae379cf7"511662STANDARDArchive/19108/7860355/Session-1-Data-Privacy-GDPR-in-Pharmacovigilance-Impact-and-Management-of-Data-Audio.m4a2021-06-17T18:26:26.000Z"ee3329cc817eb54b7371d383decdaf9e-9"140740036eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19108/7860355/Session-1-Data-Privacy-GDPR-in-Pharmacovigilance-Impact-and-Management-of-Data-Tile.jpg2021-06-17T18:26:25.000Z"5ad376aeabc13ebcde42de2719482054"77310STANDARDArchive/19108/7860355/Session-1-Data-Privacy-GDPR-in-Pharmacovigilance-Impact-and-Management-of-Data-captions.vtt2021-06-17T18:26:25.000Z"11160a454d3cf44bd72cf52d1b961117"124795eb2d4ef57f2e74142f2e7b3339dc08d425a30a920a64608d1d5b1af195255ae9STANDARDArchive/19108/7860355/Session-1-Data-Privacy-GDPR-in-Pharmacovigilance-Impact-and-Management-of-Data.jpg2021-06-17T18:26:25.000Z"6affef168e315157127426726e528f8a"425167STANDARDArchive/19108/7860355/Session-1-Data-Privacy-GDPR-in-Pharmacovigilance-Impact-and-Management-of-Data.mp42021-06-17T18:26:26.000Z"dcf802430c2ccf7f11531c0fe50d1218-8"127518998STANDARDArchive/19111/2021-06-17T18:26:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19112/2021-06-17T18:26:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19113/2021-06-17T18:26:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19114/2021-06-17T18:26:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19119/2021-06-17T18:26:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19121/2021-06-17T18:26:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19122/2021-06-17T18:26:23.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19125/2021-06-17T18:26:23.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19126/2021-06-17T18:26:23.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19128/2021-06-23T19:29:53.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19129/2021-06-23T19:29:49.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19303/2021-06-23T19:29:42.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19303/19303_ Programchairlecture_1_191110_E-1.mp42021-06-23T19:29:47.000Z"b58ca956a8178823303348c5da9468c5-51"850127885STANDARDArchive/19303/19303_ Programchairlecture_1_191110_J-1.mp42021-06-23T19:29:47.000Z"679820044f910e6e82dc5eb8ec8f54e9-51"849974533STANDARDArchive/19303/19303_Diamondsession2_1_191112_E-1.mp42021-06-23T19:29:47.000Z"20c7ac892840ea9de044121abb586169-84"1401969311STANDARDArchive/19303/19303_Diamondsession2_1_191112_J-1.mp42021-06-23T19:29:47.000Z"b6d25e5b09d337bf0a934e755287f42d-13"217278689STANDARDArchive/19303/19303_Diamondsession3_1_191112_E-1.mp42021-06-23T19:29:47.000Z"7116423c17023beeb3b2dbcc1b6c5d66-131"2186619311STANDARDArchive/19303/19303_Diamondsession3_1_191112_J-1.mp42021-06-23T19:29:47.000Z"e40515a8e006291864a32e0162b3d46b-131"2186983680STANDARDArchive/19303/19303_Diamondsessions1_1_191110_E-1.mp42021-06-23T19:29:47.000Z"e43b7098152223ab79dff481fee875f0-108"1800249856STANDARDArchive/19303/19303_Diamondsessions1_1_191110_J-1.mp42021-06-23T19:29:47.000Z"3aa44ff531b970cf04410ff44466d48d-108"1798828284STANDARDArchive/19303/8364534/2021-06-23T19:29:42.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19303/8364534/19303_Diamond-1_0_191110_E.pdf2021-06-23T19:29:42.000Z"bc1d3016d494c513393a6a6b2e984a32"176685STANDARDArchive/19303/8364534/D1-1-Fujiwara-Yasuhiro.pdf2021-06-23T19:29:42.000Z"ad4bdc2211316ccfd84f8cffa9570549"744019STANDARDArchive/19303/8364534/D1-3_IMAMURA_Kyoko.pdf2021-06-23T19:29:42.000Z"a4cac2b3f4204b1dcc881ef3614dacef"380350STANDARDArchive/19303/8364534/D1-4_IMAEDA_Takayuki.pdf2021-06-23T19:29:42.000Z"87f0a97c0caeffdc52ef785972b1a40e"551342STANDARDArchive/19303/8364534/D1_2_Saint-Raymond_Agnes.pdf2021-06-23T19:29:42.000Z"827ed4109552e0b7d9a43fad97f1467d"168533STANDARDArchive/19303/8364534/DIAmond-Session-1-What-Do-Patients-Want-for-Clinical-Trials-and-Clinical-Research-Tile.jpg2021-06-23T19:29:42.000Z"7fac023ea65abd48885a7aa7174285a1"124736STANDARDArchive/19303/8364534/DIAmond-Session-1-What-Do-Patients-Want-for-Clinical-Trials-and-Clinical-Research.jpg2021-06-23T19:29:42.000Z"c41700782085d12f4198b827beec058b"687286STANDARDArchive/19303/8364534/DIAmond-Session-1-What-Do-Patients-Want-for-Clinical-Trials-and-Clinical-Research.mp42021-06-23T19:29:47.000Z"e43b7098152223ab79dff481fee875f0-108"1800249856STANDARDArchive/19303/Originals/19303_ ProgramChairLecture_1_191110_E.mp42021-06-23T19:29:47.000Z"ecec64e7b04790ac50b7ddaad746259e-97"1617139138STANDARDArchive/19303/Originals/19303_ ProgramChairLecture_1_191110_J.mp42021-06-23T19:29:47.000Z"20465c2eb43de0f73c2b199c36cec611-97"1617139138STANDARDArchive/19303/Originals/19303_DIAmondSession2_1_191112_E.mp42021-06-23T19:29:47.000Z"39a3af8fd83e8d873f31691a646df1b9-84"1393018413STANDARDArchive/19303/Originals/19303_DIAmondSession2_1_191112_J.mp42021-06-23T19:29:47.000Z"715c79ce613180f5702fb6157a4aa00d-84"1393018413STANDARDArchive/19303/Originals/19303_DIAmondSession3_1_191112_E.mp42021-06-23T19:29:47.000Z"7015c0e37e725bfba95076b3f5ec3bc7-100"1669399097STANDARDArchive/19303/Originals/19303_DIAmondSession3_1_191112_J.mp42021-06-23T19:29:47.000Z"404da458f9e0b870e2d0c4556c7ec560-100"1669399097STANDARDArchive/19303/Originals/19303_DIAmondSessions1_1_191110_E.mp42021-06-23T19:29:47.000Z"2d40dd4616383955d155a1a49b0cc9a8-101"1684192761STANDARDArchive/19303/Originals/19303_DIAmondSessions1_1_191110_J.mp42021-06-23T19:29:47.000Z"8e50e0c903cfc8456fe9e8fbb9cec0b9-101"1684192761STANDARDArchive/19825/2021-06-23T19:29:41.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19951/2021-06-23T19:29:37.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19957/2021-06-23T19:29:36.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/19975/2021-06-23T19:29:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/2021-06-23T19:27:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/20001_02_106SL.mp42021-06-23T19:27:43.000Z"f6fe81d95eb9b2e6f4592928e02778d3-26"431355465STANDARDArchive/20001/20001_02_119L.mp42021-06-23T19:27:43.000Z"cab7458de78130717b76bb1ef5fd8880-16"256664843STANDARDArchive/20001/20001_02_129SL.mp42021-06-23T19:27:43.000Z"10d4bc3510271eca662895d8dcbcb5d3-10"160911061STANDARDArchive/20001/20001_02_202L.mp42021-06-23T19:27:44.000Z"3be8a9b057cb89dbcceff6bfc0fb857b-15"249326498STANDARDArchive/20001/20001_02_209L.mp42021-06-23T19:27:43.000Z"81ccd27c6c50b875dcfa471fdbe165ed-17"274572191STANDARDArchive/20001/20001_02_221L.mp42021-06-23T19:27:44.000Z"1a3cb537ded70d68e361eec416640c9f-43"704994092STANDARDArchive/20001/20001_02_234SL.mp42021-06-23T19:27:43.000Z"6d899c88e59db3633a56f90d24b7c6ab-15"239679336STANDARDArchive/20001/20001_02_235SL.mp42021-06-23T19:27:44.000Z"13f29d9160235229fcc6de4445996f11-15"234899898STANDARDArchive/20001/20001_02_309L.mp42021-06-23T19:27:43.000Z"1334f67e3fa30a395da9747dae97b33f-21"338122916STANDARDArchive/20001/20001_02_317L.mp42021-06-23T19:27:43.000Z"56cae37a6d6df75f86a1d00bbea30121-32"533017843STANDARDArchive/20001/20001_02_339SL.mp42021-06-23T19:27:43.000Z"fd52bdc4f1b1972991bbb2a7a0342122-33"551774854STANDARDArchive/20001/20001_02_402L.mp42021-06-23T19:27:43.000Z"a9d4b2fa35c1acd640b2e0218cb8ed0e-17"284841419STANDARDArchive/20001/20001_02_411L.mp42021-06-23T19:27:44.000Z"81e0321a78e0eb7530c7e7c0a0f33d52-16"258544967STANDARDArchive/20001/20001_02_422L.mp42021-06-23T19:27:43.000Z"08d710d965ff63306c2804cf558c7156-19"308395121STANDARDArchive/20001/20001_02_506OD.mp42021-06-23T19:27:43.000Z"c57cb892f03cd2aa92162a5c32f77923-18"293158307STANDARDArchive/20001/20001_02_507OD.mp42021-06-23T19:27:43.000Z"558a63be287ca6738a69a3ef04ef11cd-32"522273672STANDARDArchive/20001/20001_02_508OD.mp42021-06-23T19:27:43.000Z"1021a9811ff7fd0ebbda9e5306eb580d-39"648990823STANDARDArchive/20001/20001_02_509OD.mp42021-06-23T19:27:43.000Z"cfcb11c12541f911bfa9f4a2bfaf179b-35"573768330STANDARDArchive/20001/20001_02_510OD.mp42021-06-23T19:27:43.000Z"c1db20dc9c610c853c762646867b065d-49"805861332STANDARDArchive/20001/20001_02_511OD.mp42021-06-23T19:27:43.000Z"282c549dda3c6c2193902182d4b83299-39"641404196STANDARDArchive/20001/20001_02_512OD.mp42021-06-23T19:27:44.000Z"deb7b180820850d080b47dee7b09fdf4-56"928107005STANDARDArchive/20001/20001_02_513OD.mp42021-06-23T19:27:44.000Z"1c4f2654c98923fea683e281e50cba53-55"920024510STANDARDArchive/20001/20001_02_514OD.mp42021-06-23T19:27:44.000Z"b3fd3192fce61d7d836f18e959e9a701-36"587234375STANDARDArchive/20001/20001_02_515OD.mp42021-06-23T19:27:44.000Z"b6ff31ca153900b67917444f454c04e5-55"921006656STANDARDArchive/20001/20001_03_120L.mp42021-06-23T19:27:44.000Z"8ba420cd5d71f53b2dda06ba6cc2c9b4-16"261045955STANDARDArchive/20001/20001_03_130L.mp42021-06-23T19:27:44.000Z"e0bdb6de742f38d5ed8b1c0ebb46ced9-16"258078098STANDARDArchive/20001/20001_03_203L.mp42021-06-23T19:27:44.000Z"9ae17ee3767b9d4f96457483f45f93e6-16"263076885STANDARDArchive/20001/20001_03_210SL.mp42021-06-23T19:27:44.000Z"19ad4530a66af14162c2fec940ab18a6-17"270852180STANDARDArchive/20001/20001_03_236L.mp42021-06-23T19:27:44.000Z"5d9fe463ce935194bcb853c8294c07b8-25"406690732STANDARDArchive/20001/20001_03_301SL.mp42021-06-23T19:27:44.000Z"e7ea1d37469b424417d1657b8b06288f-44"737454771STANDARDArchive/20001/20001_03_318L.mp42021-06-23T19:27:44.000Z"0bd14b5a6fbfc5a5c3b0900273f8ad0c-19"314260086STANDARDArchive/20001/20001_03_516OD.mp42021-06-23T19:27:44.000Z"3f380e06435c365eb604e269b15e02b9-123"2057508743STANDARDArchive/20001/20001_03_517OD.mp42021-06-23T19:27:44.000Z"7df9f0688d2b7fd6e1a5e4186f3c9bce-68"1131436901STANDARDArchive/20001/20001_03_518OD.mp42021-06-23T19:27:44.000Z"8764b3757b104a2533cc28d848773d44-63"1050801465STANDARDArchive/20001/20001_03_519OD.mp42021-06-23T19:27:44.000Z"ab18b236c58170a36fd1028749772d85-67"1118036556STANDARDArchive/20001/20001_03_520OD.mp42021-06-23T19:27:44.000Z"95b524b0c1fe93ddef4afcb07675a247-34"569360492STANDARDArchive/20001/20001_03_521OD.mp42021-06-23T19:27:44.000Z"51d79adba40f15e4819bac95b976b021-48"804049074STANDARDArchive/20001/20001_03_553OD.mp42021-06-30T13:49:57.000Z"28aa1bce64336040826e50d7c6f9281d-54"892373636STANDARDArchive/20001/20001_04_211L.mp42021-06-23T19:27:44.000Z"56cc7dee355e1237982c67e747727e17-18"292275872STANDARDArchive/20001/20001_04_222L.mp42021-06-23T19:27:44.000Z"08a253a12e8eaf52b15738e4b5f53fe9-17"270083071STANDARDArchive/20001/20001_04_302L.mp42021-06-23T19:27:48.000Z"3a39ee4acb8214489f486fbe54608a01-17"283253140STANDARDArchive/20001/20001_04_331L.mp42021-06-23T19:27:48.000Z"4d844704d007f072f0cdce48118f744d-16"260924561STANDARDArchive/20001/20001_04_403L.mp42021-06-23T19:27:48.000Z"3e9c9a05fdcd1c8a6ca7170f4f99add5-14"233954599STANDARDArchive/20001/20001_04_412L.mp42021-06-23T19:27:48.000Z"29936d97384b04918b1ce93a31c265e9-18"295710527STANDARDArchive/20001/20001_04_423L.mp42021-06-23T19:27:48.000Z"dfff87dc972302f936bff136161efe86-27"448886060STANDARDArchive/20001/20001_04_522OD.mp42021-06-23T19:27:48.000Z"9d1962cbaa30877708e6e58340161f4e-34"560840548STANDARDArchive/20001/20001_04_524OD.mp42021-06-23T19:27:48.000Z"df746fcb01adfb00a3363dab78b353bd-36"601263265STANDARDArchive/20001/20001_04_526OD.mp42021-06-23T19:27:48.000Z"444f2c4a31a5eb27353e081963378ab4-33"544858357STANDARDArchive/20001/20001_04_554OD.mp42021-06-23T19:27:48.000Z"c11ed36085fe84cb5dc5c40c95cf4895-34"556974867STANDARDArchive/20001/20001_05_107L.mp42021-06-23T19:27:48.000Z"76c025b2a647c0d6ef577b232da907cc-11"174324594STANDARDArchive/20001/20001_05_131L.mp42021-06-23T19:27:48.000Z"a9e6c18ffb8f61e3770213291271d07c-21"343752801STANDARDArchive/20001/20001_05_212L.mp42021-06-23T19:27:48.000Z"b276cfab28c82e1670d44d4aad0cd44a-21"337639063STANDARDArchive/20001/20001_05_247SL.mp42021-06-23T19:27:48.000Z"cbff7f1d0e60857f7f035e2644f192bc-16"260076090STANDARDArchive/20001/20001_05_310L.mp42021-06-23T19:27:48.000Z"99f38d454a8d3a5da14b5a003106be91-24"392485121STANDARDArchive/20001/20001_05_332SL.mp42021-06-23T19:27:48.000Z"0664c309e9dd3f6dcd137d086c299652-14"234872556STANDARDArchive/20001/20001_05_404L.mp42021-06-23T19:27:48.000Z"f58297a7f575e8738680a6b9e95d6ae0-42"700939161STANDARDArchive/20001/20001_05_527OD.mp42021-06-23T19:27:48.000Z"aaf9811308a4eda907f2f86cefe10ed9-50"835135308STANDARDArchive/20001/20001_05_528OD.mp42021-06-23T19:27:48.000Z"92309961f37177e7d19301774c40ce2b-48"803442438STANDARDArchive/20001/20001_05_529OD.mp42021-06-23T19:27:48.000Z"f66f6a6d742b666ccf8517c9384cc5dd-41"674008142STANDARDArchive/20001/20001_05_530OD.mp42021-06-23T19:27:48.000Z"555ba326a20dcd32754a33d184521eff-223"3729813968STANDARDArchive/20001/20001_05_531OD.mp42021-06-23T19:27:49.000Z"3bda608d5ff628e3995c3c27705b9ebd-16"257041539STANDARDArchive/20001/20001_05_532OD.mp42021-06-23T19:27:49.000Z"3dccbf7b93f71e7f543193a23c2de4fa-44"727867512STANDARDArchive/20001/20001_06_108SL.mp42021-06-23T19:27:49.000Z"0f8935129e3fec909167e1ada9703d51-21"340552367STANDARDArchive/20001/20001_06_121SL.mp42021-06-23T19:27:49.000Z"743168ebd11af2de3d70d65ff7501233-12"186842121STANDARDArchive/20001/20001_06_223L.mp42021-06-23T19:27:49.000Z"5a83c72e6c59d038d195257a97f7937f-45"751826685STANDARDArchive/20001/20001_06_237L.mp42021-06-23T19:27:49.000Z"fd3dfcee67fecbcc100ec683025d2c5c-44"727860845STANDARDArchive/20001/20001_06_311L.mp42021-06-23T19:27:49.000Z"1c2e1e264f68a99470170561065dc077-16"266659793STANDARDArchive/20001/20001_06_413L.mp42021-06-23T19:27:49.000Z"63b118dd1dca84ce1152ec0485ce7baf-21"344550090STANDARDArchive/20001/20001_06_533OD.mp42021-06-23T19:27:49.000Z"bc54d29ba03e58d05bc36498549291b8-40"669842124STANDARDArchive/20001/20001_06_534OD.mp42021-06-23T19:27:49.000Z"c32b465bc96fcf7b754936c9bb5e03ff-54"889221566STANDARDArchive/20001/20001_06_535OD.mp42021-06-23T19:27:49.000Z"d95a1141b7ac347a4a68186d1a063612-62"1025091474STANDARDArchive/20001/20001_06_536OD.mp42021-06-23T19:27:49.000Z"85f55a0475243d69eeb741853df40aed-32"522943262STANDARDArchive/20001/20001_06_537OD.mp42021-06-23T19:27:49.000Z"65a01f15dbfa80dc43731e5b951a5832-55"914729288STANDARDArchive/20001/20001_07_213L.mp42021-06-23T19:27:49.000Z"2458ffb4ab141af9baf1e8a820a6d6a9-17"268780374STANDARDArchive/20001/20001_07_248L.mp42021-06-23T19:27:49.000Z"0233ebd5f3f045e4ca0cff1d747f22a4-18"300162039STANDARDArchive/20001/20001_07_319L.mp42021-06-23T19:27:49.000Z"3b78acedd61a56375c693aadaf4979f6-17"283713124STANDARDArchive/20001/20001_07_340SL.mp42021-06-23T19:27:49.000Z"ceff9acb245b446394ef20a5d7ffeeb2-16"263636368STANDARDArchive/20001/20001_07_538OD.mp42021-06-23T19:27:49.000Z"1e4401308366ff8cf064419a0bf02662-22"358679026STANDARDArchive/20001/20001_07_539OD.mp42021-06-23T19:27:49.000Z"7e92a1ddef238d3c9c4b7f87938fde57-40"656696425STANDARDArchive/20001/20001_07_540OD.mp42021-06-23T19:27:49.000Z"c321f1852ef2028886ced1d3b2bf71d5-26"429666221STANDARDArchive/20001/20001_09_109L.mp42021-06-23T19:27:52.000Z"25c2821ec8ede8fad5bf46d4d8e0cf76-16"258972754STANDARDArchive/20001/20001_09_123L.mp42021-06-23T19:27:52.000Z"4045a1196c6fd8ea0c34976a6e6c7eef-17"282142037STANDARDArchive/20001/20001_09_133L.mp42021-06-23T19:27:52.000Z"792790210e359641b53ef28ef9e886fe-19"306288810STANDARDArchive/20001/20001_09_205SL.mp42021-06-23T19:27:52.000Z"e7ceb3dea6a193db3a31fcd9b1504632-17"272691241STANDARDArchive/20001/20001_09_215L.mp42021-06-23T19:27:52.000Z"549a49bc93255ef367b1741ca3f3098d-54"899337294STANDARDArchive/20001/20001_09_225L.mp42021-06-23T19:27:52.000Z"01e5eec898c48c12bf47f6964ea00dce-18"291787605STANDARDArchive/20001/20001_09_238SL.mp42021-06-23T19:27:52.000Z"246aa317f1cab9748aecd48cc87ee3d5-12"198507733STANDARDArchive/20001/20001_09_304.1L.mp42021-06-23T19:27:52.000Z"dd4c93540d4508bfa51e4b15e38ce48c-25"407668274STANDARDArchive/20001/20001_09_304L.mp42021-06-23T19:27:52.000Z"9a06019a2368ac8238a9055be71518cb-13"206849796STANDARDArchive/20001/20001_09_312L.mp42021-06-23T19:27:52.000Z"30c3f85e4f06b34b6804ffe3163b2cfa-22"362855090STANDARDArchive/20001/20001_09_320L.mp42021-06-23T19:27:52.000Z"d012711c4e05ccc37ae3aac354d99807-22"366326058STANDARDArchive/20001/20001_09_334L.mp42021-06-23T19:27:52.000Z"df1f89f282da9c615fdc7afcfcdf65a2-17"283140430STANDARDArchive/20001/20001_09_405L.mp42021-06-23T19:27:52.000Z"1a8674cc9e51656fd488cd466c4d9168-16"252072863STANDARDArchive/20001/20001_09_406SL.mp42021-06-23T19:27:52.000Z"98583c0f4825f9f436f1a8fa77516302-17"274884019STANDARDArchive/20001/20001_09_549OD.mp42021-06-23T19:27:52.000Z"db4ad7f32c9d71327634e9e34c08ef46-34"559292464STANDARDArchive/20001/20001_09_550OD.mp42021-06-23T19:27:52.000Z"61369376e66e13da6e6088327f579122-45"745939150STANDARDArchive/20001/20001_09_551OD.mp42021-06-23T19:27:52.000Z"3da7ecf7f841c9a422d0e3e640d94e14-54"903623001STANDARDArchive/20001/20001_09_552OD.mp42021-06-23T19:27:52.000Z"49df516f085432e9251d59883f0db7b9-62"1028628301STANDARDArchive/20001/20001_10_124SL.mp42021-06-23T19:27:52.000Z"19e0ccdc6586e29401d3d760a9014175-51"844549732STANDARDArchive/20001/20001_10_206L.mp42021-06-23T19:27:52.000Z"b8f470fb2dab2399997dcc3640dcbe55-47"777793712STANDARDArchive/20001/20001_10_414SL.mp42021-06-23T19:27:53.000Z"faa9345de1a26cfbd697a3e786de06f9-15"240073915STANDARDArchive/20001/20001_10_556OD.mp42021-06-23T19:27:53.000Z"ff5890d3f44535da98c57fe89130620d-37"616041543STANDARDArchive/20001/20001_10_557OD.mp42021-06-23T19:27:53.000Z"59ed0014cdba4a47ef7743f8f65068e7-53"885923944STANDARDArchive/20001/20001_10_558OD.mp42021-06-23T19:27:53.000Z"940646ba983668e6187d043f458cddbf-50"832774117STANDARDArchive/20001/20001_11_239L.mp42021-06-23T19:27:53.000Z"3cd1e8b2c2f4015d017d624d7c37e678-19"305802828STANDARDArchive/20001/20001_11_249L.mp42021-06-23T19:27:53.000Z"baa6d6d01a82ad2ca361648861261c8f-20"330876631STANDARDArchive/20001/20001_11_306L.mp42021-06-23T19:27:53.000Z"870184fd4ca32d4cfeca8b183eb1eb38-16"256105965STANDARDArchive/20001/20001_11_341L.mp42021-06-23T19:27:53.000Z"fe28bf319f7f6ee9c525cc5e8489e9b2-28"467705454STANDARDArchive/20001/20001_11_410SL.mp42021-06-23T19:27:53.000Z"1c925240b78df644ebae56dba9effc55-11"170298406STANDARDArchive/20001/20001_11_415SL.mp42021-06-23T19:27:53.000Z"eb4ac52e25d1d0d32fa7e7d02192dd07-11"167815215STANDARDArchive/20001/20001_11_559OD.mp42021-06-23T19:27:53.000Z"d8915551a301ef3f12c91c76aac6ae96-70"1162135152STANDARDArchive/20001/20001_11_560OD.mp42021-06-23T19:27:53.000Z"6d253d68102f4127c0048e3a2a2c5556-33"546763260STANDARDArchive/20001/20001_11_561OD.mp42021-06-23T19:27:53.000Z"d24329d00bda9db3736491e934b200eb-29"482721321STANDARDArchive/20001/20001_11_562OD.mp42021-06-23T19:27:53.000Z"be57d3f134ccb41063fe1bfa7c681d97-38"628086160STANDARDArchive/20001/20001_11_563OD.mp42021-06-23T19:27:53.000Z"b040bd0b80d94b21fe44d4eb756da34f-42"697833110STANDARDArchive/20001/20001_12_110L.mp42021-06-23T19:27:53.000Z"28f2d83997dda06e78af69f200a2b224-19"302792517STANDARDArchive/20001/20001_12_134L.mp42021-06-23T19:27:53.000Z"81d56038bb007dd5868e33a580aff6e7-16"255679688STANDARDArchive/20001/20001_12_240L-SB.mp42021-06-23T19:27:53.000Z"e8bb48bd00bc7ed32727477c8d949080-22"363967383STANDARDArchive/20001/20001_12_321L.mp42021-06-23T19:27:53.000Z"378e902ff73669b098fde402a9a96e4f-19"304164003STANDARDArchive/20001/20001_12_342L.mp42021-06-23T19:27:53.000Z"fe2e1dc8331bf1597e921e30ff75365d-18"292447397STANDARDArchive/20001/20001_12_564OD.mp42021-06-23T19:28:00.000Z"fd428ef35c27dcbc2f8bb7bb68160761-51"839819281STANDARDArchive/20001/20001_12_565OD.mp42021-06-23T19:28:00.000Z"52b32da3a8ea9aa4a64e6651ef858c2e-45"744773730STANDARDArchive/20001/20001_12_566OD.mp42021-06-23T19:28:00.000Z"fd0d67ab84901ef2daff64cac144dc8a-53"884837242STANDARDArchive/20001/20001_12_567OD.mp42021-06-23T19:28:00.000Z"4bbceecbb93c217dbf32f657e487bfec-57"947399431STANDARDArchive/20001/20001_13_250L.mp42021-06-23T19:28:00.000Z"cec9ca8265991cab65037b93cce8ddff-20"325825391STANDARDArchive/20001/20001_13_505OD.mp42021-06-23T19:28:00.000Z"0a47e4cb0d160ef0bd8ca81cc40be90d-68"1132649706STANDARDArchive/20001/20001_13_568OD.mp42021-06-23T19:28:00.000Z"eaadcc0b357a1efd22d2d109713e2236-24"385991274STANDARDArchive/20001/20001_13_570OD.mp42021-06-23T19:28:01.000Z"81f7f25930c46f214934d84d8d65d3ee-30"492928800STANDARDArchive/20001/20001_20_431L.mp42021-06-23T19:28:00.000Z"4aaab46164d3249d3c2a076b89375449-84"1405704082STANDARDArchive/20001/20001_Plenary_1.mp42021-06-23T19:28:00.000Z"19d5609bbf3c72988aa73b162c9b5f01-116"1933483042STANDARDArchive/20001/8689653/2021-06-23T19:27:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689653/20001-01-330-L-Audio.m4a2021-06-23T19:28:00.000Z"a25e791b8aa2a9a4e1bd35abcc25ff3f-4"56999602STANDARDArchive/20001/8689653/20001-01-330-L-Tile.jpg2021-06-23T19:27:24.000Z"4573c448185231842891dcc4b7774857"107437STANDARDArchive/20001/8689653/20001-01-330-L.jpg2021-06-23T19:27:24.000Z"175ca7165224b346b98f2361d1f073f1"654530STANDARDArchive/20001/8689653/20001-01-330-L.mp42021-06-23T19:28:00.000Z"33cda03258d7c43862cdd4e6e19d7ba4-25"410180453STANDARDArchive/20001/8689653/20001_330-L_Grabowski_Neal.pdf2021-06-23T19:27:24.000Z"efd54f523ccbce819e70bae1e05f1ae1"1458282STANDARDArchive/20001/8689656/2021-06-23T19:27:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689656/20001-01-233-L-Audio.m4a2021-06-23T19:28:00.000Z"0965dd806361217634be3de1d51f3a0f-4"59788597STANDARDArchive/20001/8689656/20001-01-233-L-Tile.jpg2021-06-23T19:27:24.000Z"9e0aedf312a6cdf292c8f6c40b9e80d0"104336STANDARDArchive/20001/8689656/20001-01-233-L.jpg2021-06-23T19:27:24.000Z"241d24ca2987b2e879eae18e735fb922"630963STANDARDArchive/20001/8689656/20001-01-233-L.mp42021-06-23T19:28:00.000Z"3a06dc7ad1745c51fc65138c03f3e4fd-18"299357074STANDARDArchive/20001/8689656/20001_233-L_Gilsenan_Alicia.pdf2021-06-23T19:27:24.000Z"3544436bf53ca743ab2bd4d4d2238549"351571STANDARDArchive/20001/8689656/20001_233-L_LaCivita_Cynthia.pdf2021-06-23T19:27:24.000Z"0d584d8655a472589d26e6591a23b792"776670STANDARDArchive/20001/8689656/20001_233-L_Rubino_Annalisa.pdf2021-06-23T19:27:24.000Z"7e24be1269e1a674c6fc5e57e7b42a84"1368567STANDARDArchive/20001/8689656/20001_233-L_Smith_Meredith.pdf2021-06-23T19:27:24.000Z"d16211949c7a28cf39845f155cb12385"715306STANDARDArchive/20001/8689658/2021-06-23T19:27:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689658/20001-01-246S-L-Audio.m4a2021-06-23T19:28:00.000Z"cef93ed1b7d32365e5a258937e37c17a-3"44977238STANDARDArchive/20001/8689658/20001-01-246S-L-Tile.jpg2021-06-23T19:27:24.000Z"db243db4dcb9ba7bd717532121ee81ef"71954STANDARDArchive/20001/8689658/20001-01-246S-L.jpg2021-06-23T19:27:24.000Z"d77d2640f0e04a8e45349ad3b729ad2a"489689STANDARDArchive/20001/8689658/20001-01-246S-L.mp42021-06-23T19:28:00.000Z"a40fe9c8bdbff3b792c13133daa4e0fa-10"167558790STANDARDArchive/20001/8689660/2021-06-23T19:27:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689660/20001-01-316-SL-Audio.m4a2021-06-23T19:28:00.000Z"25f4b50b03c1e18e503038a840fc45e9-3"49754233STANDARDArchive/20001/8689660/20001-01-316-SL-Tile.jpg2021-06-23T19:27:24.000Z"2bf7255850952ac596eed1a30ba773a2"67330STANDARDArchive/20001/8689660/20001-01-316-SL.jpg2021-06-23T19:27:24.000Z"a281a7409e0ddc2a8ac949c067827bc6"481735STANDARDArchive/20001/8689660/20001-01-316-SL.mp42021-06-23T19:28:00.000Z"381043375331baab3f5b73669b1003bc-25"408271275STANDARDArchive/20001/8689660/20001_316-SL_Avigan_Mark.pdf2021-06-23T19:27:24.000Z"60a34f990f8121308148f799b55d6e5e"305822STANDARDArchive/20001/8689660/20001_316-SL_Fontana_Robert.pdf2021-06-23T19:27:24.000Z"7d07d28c8bca0b29142ac6734ac773c8"487895STANDARDArchive/20001/8689660/20001_316-SL_Le-Louet_Herve.pdf2021-06-23T19:27:24.000Z"ece7afce75d137e6a3453b0626b85b4b"382370STANDARDArchive/20001/8689660/20001_316-SL_Regev_Arie.pdf2021-06-23T19:27:24.000Z"916b43bcbf8bbffbe14e0aafb4d9d547"723121STANDARDArchive/20001/8689660/20001_316-SL_Straus_Walter.pdf2021-06-23T19:27:24.000Z"d0d20c412c52754be20e59bc02708e73"940112STANDARDArchive/20001/8689663/2021-06-23T19:27:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689663/20001-01-502-OD-Audio.m4a2021-06-23T19:28:00.000Z"e22caec21af27be459fefeb0d7298811-3"47509885STANDARDArchive/20001/8689663/20001-01-502-OD-Tile.jpg2021-06-23T19:27:24.000Z"eb8fab0ba4e8ea82010da85088c016a8"77268STANDARDArchive/20001/8689663/20001-01-502-OD.jpg2021-06-23T19:27:24.000Z"7ed2b1cea0c63194b646d10fd101eb7f"551956STANDARDArchive/20001/8689663/20001-01-502-OD.mp42021-06-23T19:28:00.000Z"45213061799cb425d3d4eaa5c4bbfa36-43"718269447STANDARDArchive/20001/8689663/20001_502-OD_Johnson_Calvin-1.pdf2021-06-23T19:27:24.000Z"1bd022c8ba3675e332b90fc9904da758"397477STANDARDArchive/20001/8689663/20001_502-OD_Levens_Heidi.pdf2021-06-23T19:27:24.000Z"a67f4f4153dd76910c0591d10aca778b"632919STANDARDArchive/20001/8689663/20001_502-OD_Trevett_Kiernan.pdf2021-06-23T19:27:24.000Z"54fa4e08fc736620d6a88edb8bf2cd96"450131STANDARDArchive/20001/8689740/2021-06-23T19:27:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689740/20001-01-105-SL-Audio.m4a2021-06-23T19:28:01.000Z"a6cad706ebe519da7fd65ddd48e7e8ba-4"57718492STANDARDArchive/20001/8689740/20001-01-105-SL-Tile.jpg2021-06-23T19:27:24.000Z"e36bb7de73d89b29075a5e52ff67819e"76720STANDARDArchive/20001/8689740/20001-01-105-SL.jpg2021-06-23T19:27:24.000Z"57986f11d3016fa9bc220c0b62c88751"463030STANDARDArchive/20001/8689740/20001-01-105-SL.mp42021-06-23T19:28:01.000Z"0355641be806688ba6b7e27107cc2239-13"216186081STANDARDArchive/20001/8689740/20001_105-SL-Matsui-Rie-1 .pdf2021-06-23T19:27:24.000Z"6859b247ed31d940bd996e6eab2c162f"222613STANDARDArchive/20001/8689740/20001_105-SL_Roberts_Khyati.pdf2021-06-23T19:27:24.000Z"b19c2a1554e33d1d8d8b8e5d349f08c4"362405STANDARDArchive/20001/8689740/20001_105-SL_Sato_Junko.pdf2021-06-23T19:27:24.000Z"85989dfc31c34a34de7833ebc6968b9b"1522393STANDARDArchive/20001/8689740/20001_105-SL_Scanlan_Elizabeth.pdf2021-06-23T19:27:24.000Z"a5ca3342d50eb0a90692e9700018bd4e"463723STANDARDArchive/20001/8689740/20001_105SL-Matsui-Rie-2.pdf2021-06-23T19:27:24.000Z"fecf296cccac9738c147d681ce796b59"993636STANDARDArchive/20001/8689742/2021-06-23T19:27:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689742/20001-01-503-OD-Audio.m4a2021-06-23T19:28:01.000Z"70179f7a5002ffbacccd9b6f085e8594-3"47372423STANDARDArchive/20001/8689742/20001-01-503-OD-Tile.jpg2021-06-23T19:27:24.000Z"ff81a67cbdc05928b06396a68a7c064f"86632STANDARDArchive/20001/8689742/20001-01-503-OD.jpg2021-06-23T19:27:24.000Z"24a0475c2fec2187ee4ed0a6ce7b0835"602670STANDARDArchive/20001/8689742/20001-01-503-OD.mp42021-06-23T19:28:01.000Z"d6462e7d2a7111d5051a92106427fdae-34"558207657STANDARDArchive/20001/8689752/2021-06-23T19:27:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689752/20001-01-220-L-Audio.m4a2021-06-23T19:28:01.000Z"fc17af04b8544e19c80987ab519cdc9f-3"50120180STANDARDArchive/20001/8689752/20001-01-220-L-Tile.jpg2021-06-23T19:27:31.000Z"2c95e6a5c42be911f41f19adbd873446"87770STANDARDArchive/20001/8689752/20001-01-220-L.jpg2021-06-23T19:27:31.000Z"fdcf6fd395e81faa648fa05e6f719219"566018STANDARDArchive/20001/8689752/20001-01-220-L.mp42021-06-23T19:28:02.000Z"292e77e5c77f6c1ee22ed4162367bffe-18"289205509STANDARDArchive/20001/8689752/20001_220-L_Hochberg_Alan.pdf2021-06-23T19:27:31.000Z"8a49ff805aed5a4d5d1504440efe913e"551779STANDARDArchive/20001/8689759/2021-06-23T19:27:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689759/20001-01-504-OD-Audio.m4a2021-06-23T19:28:01.000Z"4d0d3fa6a19875a6b1487b1d82c7f170-4"55857923STANDARDArchive/20001/8689759/20001-01-504-OD-Tile.jpg2021-06-23T19:27:31.000Z"cc648cb9d073a944989fd3536c8c4e63"78002STANDARDArchive/20001/8689759/20001-01-504-OD.jpg2021-06-23T19:27:31.000Z"9a3192e5ca98b5aa5a21c8465e70efc5"510627STANDARDArchive/20001/8689759/20001-01-504-OD.mp42021-06-23T19:28:02.000Z"f13700f558b23f5516ace0d7e9d00e2d-41"672371206STANDARDArchive/20001/8689759/20001_504-OD_McNair_Lindsay.pdf2021-06-23T19:27:31.000Z"e0d77bcf27f67607ebd00c8244a19422"1086876STANDARDArchive/20001/8689763/2021-06-23T19:27:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689763/20001-01-338-L-Audio.m4a2021-06-23T19:28:01.000Z"18fcea1b73cc673bd1c51aa5ddca807b-4"56843936STANDARDArchive/20001/8689763/20001-01-338-L-Tile.jpg2021-06-23T19:27:31.000Z"02baee3408b211b3cbffcbd2279966c2"88559STANDARDArchive/20001/8689763/20001-01-338-L.jpg2021-06-23T19:27:31.000Z"a67479388933c0adb5136083dbfea1c9"572708STANDARDArchive/20001/8689763/20001-01-338-L.mp42021-06-23T19:28:01.000Z"cd5e399dbfc75fe90b3e6b0bec3a5f19-20"323862717STANDARDArchive/20001/8689763/20001_338-L_Blum_Michael.pdf2021-06-23T19:27:31.000Z"54c176fb4855dd4d3c8e8234d2b59b76"401691STANDARDArchive/20001/8689763/20001_338-L_Strand_Vibeke.pdf2021-06-23T19:27:31.000Z"a4378c6bf2ae571b05de1c31bb577e7f"2883590STANDARDArchive/20001/8689763/20001_338-L_Tresnan_Dina.pdf2021-06-23T19:27:31.000Z"14dbe7d65cccf15dad25a997cb2738fe"979000STANDARDArchive/20001/8689763/20001_338-L_Verthelyi_Daniela.pdf2021-06-23T19:27:31.000Z"591fa854294e509de6c1bf4b28cb832b"918589STANDARDArchive/20001/8689774/2021-06-23T19:27:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689774/20001-01-421-L-Audio.m4a2021-06-23T19:28:01.000Z"ba398ba34a66af07ed3ef35e2d4066d6-4"57406044STANDARDArchive/20001/8689774/20001-01-421-L-Tile.jpg2021-06-23T19:27:31.000Z"b2fa7b59554dc03d17e3e6c20388371f"98453STANDARDArchive/20001/8689774/20001-01-421-L.jpg2021-06-23T19:27:31.000Z"f84998d9e1cf63eff00c0be653c8eefc"618389STANDARDArchive/20001/8689774/20001-01-421-L.mp42021-06-23T19:28:02.000Z"90494a03136e1f9d622fd88479efa3de-32"520847956STANDARDArchive/20001/8689774/20001_421-L_DiSantostefano_Rachael.pdf2021-06-23T19:27:31.000Z"521a7c7344d576540056261fdfbb9693"484092STANDARDArchive/20001/8689774/20001_421-L_Hauber_Brett.pdf2021-06-23T19:27:31.000Z"cb05d4e627698c49401ac725bd31fccd"489701STANDARDArchive/20001/8689774/20001_421-L_Marsh_Kevin.pdf2021-06-23T19:27:31.000Z"bd7e6ab194112b52a6a538b40b4fab99"462207STANDARDArchive/20001/8689774/20001_421-L_Smith_Meredith-1.pdf2021-06-23T19:27:31.000Z"1e10a2edbde4e27fde7c4c90c38f4e3d"395737STANDARDArchive/20001/8689774/20001_421-L_Smith_Meredith.pdf2021-06-23T19:27:31.000Z"2c5698c8a7350caa697343487c952d95"295078STANDARDArchive/20001/8689776/2021-06-23T19:27:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689776/20001-01-201-L-Audio.m4a2021-06-23T19:28:01.000Z"7629fef8e9125aa7fb2a375e49825a75-4"57245176STANDARDArchive/20001/8689776/20001-01-201-L-Tile.jpg2021-06-23T19:27:31.000Z"d183d3f5ffa22a791c8b0eb01e73a4da"97658STANDARDArchive/20001/8689776/20001-01-201-L.jpg2021-06-23T19:27:31.000Z"a47d8efd3bfb8ea9a757e7f93219075a"604998STANDARDArchive/20001/8689776/20001-01-201-L.mp42021-06-23T19:28:01.000Z"9c9a425e572247156e0753c54e54854f-18"294011133STANDARDArchive/20001/8689776/20001_201-L_Bent_Robyn.pdf2021-06-23T19:27:31.000Z"1c46f96a07cfb54a17ffec65552c1c20"1522653STANDARDArchive/20001/8689776/20001_201-L_Boerstoel-Streefland_Mariette.pdf2021-06-23T19:27:31.000Z"c82ae80c711efa1b1be9db7934d91372"351902STANDARDArchive/20001/8689776/20001_201-L_Capperella_Katherine.pdf2021-06-23T19:27:31.000Z"8547ff148cae58969b3ea884395bae6f"423667STANDARDArchive/20001/8689776/20001_201-L_Oehrlein_Elisabeth.pdf2021-06-23T19:27:31.000Z"790dfde083801129e0958f2301fd0eac"2415883STANDARDArchive/20001/8689776/20001_201-L_Schuitmaker_Tjerk-Jan.pdf2021-06-23T19:27:31.000Z"785088d7b9a8bbaac35fe038d8ebb7bf"1182410STANDARDArchive/20001/8689778/2021-06-23T19:27:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689778/20001-01-401-L-Audio.m4a2021-06-23T19:28:01.000Z"22b1ef87a63688c0c364f0a25790d466-4"57958122STANDARDArchive/20001/8689778/20001-01-401-L-Tile.jpg2021-06-23T19:27:31.000Z"2ecfe22a682ff1f7b3be10411db2c5ad"86471STANDARDArchive/20001/8689778/20001-01-401-L.jpg2021-06-23T19:27:31.000Z"0c5e1e628c3fd912de97427dee468fc4"556238STANDARDArchive/20001/8689778/20001-01-401-L.mp42021-06-23T19:28:01.000Z"883b2796eb19697b26815764c5ac58df-18"285367844STANDARDArchive/20001/8689778/20001_401-L_Barrett_Carla.pdf2021-06-23T19:27:31.000Z"031cbf4b3320155e3acfec25b80e6af4"1029800STANDARDArchive/20001/8689778/20001_401-L_Smith_Meredith.pdf2021-06-23T19:27:31.000Z"0e8f2d866c7a71462ff46707f80da6b6"698586STANDARDArchive/20001/8689778/20001_401-L_Tabatabaei_Fakhredin.pdf2021-06-23T19:27:31.000Z"b112590545a83d0940c2b0a0ef5d53f6"804608STANDARDArchive/20001/8689778/20001_401-L_Toyserkani_Gita.pdf2021-06-23T19:27:31.000Z"68061e4a5d6f2e5a95af2a60fc59266d"742426STANDARDArchive/20001/8689859/2021-06-23T19:27:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDArchive/20001/8689859/20001-0205S87401-Kunkoski-Elizabeth.jpg2021-06-23T19:27:31.000Z"87a6d0b7aea533c5a57f027f1ae3ce9f"37421STANDARD